JPH0441156B2 - - Google Patents
Info
- Publication number
- JPH0441156B2 JPH0441156B2 JP58127033A JP12703383A JPH0441156B2 JP H0441156 B2 JPH0441156 B2 JP H0441156B2 JP 58127033 A JP58127033 A JP 58127033A JP 12703383 A JP12703383 A JP 12703383A JP H0441156 B2 JPH0441156 B2 JP H0441156B2
- Authority
- JP
- Japan
- Prior art keywords
- methanol
- ylcarbonyl
- glycinamide
- group
- prolyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 2,2-indanediyl group Chemical group 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 7
- 150000007513 acids Chemical class 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000006638 cyclopentyl carbonyl group Chemical group 0.000 claims description 2
- 125000001624 naphthyl group Chemical group 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 12
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 8
- NOOJLZTTWSNHOX-UWVGGRQHSA-N Melanostatin Chemical compound NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 NOOJLZTTWSNHOX-UWVGGRQHSA-N 0.000 abstract description 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 108010064699 MSH Release-Inhibiting Hormone Proteins 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 168
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 66
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 62
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 57
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 42
- 230000008018 melting Effects 0.000 description 32
- 238000002844 melting Methods 0.000 description 32
- 239000000243 solution Substances 0.000 description 31
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 27
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 27
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 27
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 18
- 150000001875 compounds Chemical class 0.000 description 18
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 13
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 229910052938 sodium sulfate Inorganic materials 0.000 description 12
- 235000011152 sodium sulphate Nutrition 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 229910000029 sodium carbonate Inorganic materials 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 150000008065 acid anhydrides Chemical class 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 125000006239 protecting group Chemical group 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229910052763 palladium Inorganic materials 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- WKNMKGVLOWGGOU-UHFFFAOYSA-N 2-aminoacetamide;hydron;chloride Chemical compound Cl.NCC(N)=O WKNMKGVLOWGGOU-UHFFFAOYSA-N 0.000 description 4
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 150000004702 methyl esters Chemical class 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 3
- JXGVXCZADZNAMJ-NSHDSACASA-N (2s)-1-phenylmethoxycarbonylpyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)OCC1=CC=CC=C1 JXGVXCZADZNAMJ-NSHDSACASA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 3
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- QCHFTSOMWOSFHM-UHFFFAOYSA-N SJ000285536 Natural products C1OC(=O)C(CC)C1CC1=CN=CN1C QCHFTSOMWOSFHM-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000003610 charcoal Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 239000008298 dragée Substances 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 description 3
- 230000020477 pH reduction Effects 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 229960001416 pilocarpine Drugs 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 150000003892 tartrate salts Chemical class 0.000 description 3
- KBCGSTGFOMUOGZ-VIFPVBQESA-N (2s)-n-(1-aminocyclopentanecarbonyl)-n-(2-amino-2-oxoethyl)pyrrolidine-2-carboxamide Chemical compound C1CCCC1(N)C(=O)N(CC(=O)N)C(=O)[C@@H]1CCCN1 KBCGSTGFOMUOGZ-VIFPVBQESA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical compound CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 description 2
- 229930182819 D-leucine Natural products 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- 239000004395 L-leucine Substances 0.000 description 2
- 235000019454 L-leucine Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 208000018737 Parkinson disease Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 229960003638 dopamine Drugs 0.000 description 2
- 230000003291 dopaminomimetic effect Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 150000002332 glycine derivatives Chemical class 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229960003136 leucine Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- WRHZVMBBRYBTKZ-UHFFFAOYSA-N pyrrole-2-carboxylic acid Chemical compound OC(=O)C1=CC=CN1 WRHZVMBBRYBTKZ-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000007940 sugar coated tablet Substances 0.000 description 2
- 238000009495 sugar coating Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- DHFZBEMDPFVXMM-UONOGXRCSA-N (2S)-N-[(2R)-1-[(2-amino-2-oxoethyl)amino]-3-(2-methylphenyl)-1-oxopropan-2-yl]pyrrolidine-2-carboxamide Chemical compound N1[C@@H](CCC1)C(=O)N[C@H](CC1=C(C=CC=C1)C)C(=O)NCC(=O)N DHFZBEMDPFVXMM-UONOGXRCSA-N 0.000 description 1
- MQTHKCSECHVWGN-ZETCQYMHSA-N (2s)-n-(1-aminocyclopropanecarbonyl)-n-(2-amino-2-oxoethyl)pyrrolidine-2-carboxamide Chemical compound C1CC1(N)C(=O)N(CC(=O)N)C(=O)[C@@H]1CCCN1 MQTHKCSECHVWGN-ZETCQYMHSA-N 0.000 description 1
- KUESDHSZAOXTPM-ZDUSSCGKSA-N (2s)-n-(2-amino-1,3-dihydroindene-2-carbonyl)-n-(2-amino-2-oxoethyl)pyrrolidine-2-carboxamide Chemical compound C1C2=CC=CC=C2CC1(N)C(=O)N(CC(=O)N)C(=O)[C@@H]1CCCN1 KUESDHSZAOXTPM-ZDUSSCGKSA-N 0.000 description 1
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical group OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 208000009132 Catalepsy Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000001358 L(+)-tartaric acid Substances 0.000 description 1
- 235000011002 L(+)-tartaric acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-LWMBPPNESA-N L-(+)-Tartaric acid Natural products OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- 229920004011 Macrolon® Polymers 0.000 description 1
- 239000000637 Melanocyte-Stimulating Hormone Substances 0.000 description 1
- 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 208000026251 Opioid-Related disease Diseases 0.000 description 1
- DPWPWRLQFGFJFI-UHFFFAOYSA-N Pargyline Chemical compound C#CCN(C)CC1=CC=CC=C1 DPWPWRLQFGFJFI-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 206010047853 Waxy flexibility Diseases 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000000648 anti-parkinson Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000000939 antiparkinson agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 238000009227 behaviour therapy Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229940127243 cholinergic drug Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- AUONNNVJUCSETH-UHFFFAOYSA-N icosanoyl icosanoate Chemical compound CCCCCCCCCCCCCCCCCCCC(=O)OC(=O)CCCCCCCCCCCCCCCCCCC AUONNNVJUCSETH-UHFFFAOYSA-N 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000006742 locomotor activity Effects 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- VLNNACMZTDZCFH-UHFFFAOYSA-N methyl 1-aminocyclopentane-1-carboxylate Chemical compound COC(=O)C1(N)CCCC1 VLNNACMZTDZCFH-UHFFFAOYSA-N 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 230000003227 neuromodulating effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 201000005040 opiate dependence Diseases 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229960001779 pargyline Drugs 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- DOYOPBSXEIZLRE-UHFFFAOYSA-N pyrrole-3-carboxylic acid Natural products OC(=O)C=1C=CNC=1 DOYOPBSXEIZLRE-UHFFFAOYSA-N 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000007885 tablet disintegrant Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯ãæ°èŠãªããããã®ïŒ®âã¢ã·ã«èªå°äœ
ã«é¢ããã
ã«é¢ããã
ããªããããã§ããâProââLeuâGly
âNH2ïŒMIFïŒã¯ãã¡ã©ãã³çŽ°èåºæ¿ãã«ã¢ã³ã§
ããïŒã¡ã«ã¯ã€ã³ããã¯ã¹ïŒç1976幎åç §ïŒãå
åæ³äœçšã®ã»ãã«ãã®ããªããããã¯ãäžæ¢ç¥çµ
ç³»ã«ç¥çµäŒéå¹æåã¯ç¥çµå€èª¿å¹æãäžãããèš
åºç 究ã«ãããšãMIFã¯ãåç¬ã§åã¯ïŒ¬âDopa
ãšçµã¿åãããŠãããŒãã³ãœã³ç æ£è ã®ãµããã
硬çŽåã³å€±åç ã«è¯å¥œãªåœ±é¿ãäžããïŒCan.
Med.Assoc.J.107å·»1097é 1972幎åã³Wien.Klin.
Wschr.87å·»822é 1975幎åç §ïŒãããããã®ããª
ããããã®å¹ åºãæ²»çäžã®å¿çšã¯ãäžæºè¶³ãªçµå£
掻æ§åã³çãäœçšæéã«ãã€ãŠåŠšããããã
âNH2ïŒMIFïŒã¯ãã¡ã©ãã³çŽ°èåºæ¿ãã«ã¢ã³ã§
ããïŒã¡ã«ã¯ã€ã³ããã¯ã¹ïŒç1976幎åç §ïŒãå
åæ³äœçšã®ã»ãã«ãã®ããªããããã¯ãäžæ¢ç¥çµ
ç³»ã«ç¥çµäŒéå¹æåã¯ç¥çµå€èª¿å¹æãäžãããèš
åºç 究ã«ãããšãMIFã¯ãåç¬ã§åã¯ïŒ¬âDopa
ãšçµã¿åãããŠãããŒãã³ãœã³ç æ£è ã®ãµããã
硬çŽåã³å€±åç ã«è¯å¥œãªåœ±é¿ãäžããïŒCan.
Med.Assoc.J.107å·»1097é 1972幎åã³Wien.Klin.
Wschr.87å·»822é 1975幎åç §ïŒãããããã®ããª
ããããã®å¹ åºãæ²»çäžã®å¿çšã¯ãäžæºè¶³ãªçµå£
掻æ§åã³çãäœçšæéã«ãã€ãŠåŠšããããã
âProââLeuâGlyâNH2ã®è¬çäœçšã
ä¿æããªãããååæ§é ã®å€æŽã«ãã€ãŠçµå£æŽ»æ§
åã³é·ãäœçšæéãæããååç©ãåŸãããšãè©Š
ã¿ãããããã®åªåã¯äžå€®ã«ããâãã€ã·ã³ã
âãã€ã·ã³ã«ïŒç±³åœç¹èš±4278595å·ïŒåã¯ïŒ¬â
ãããã¯ïŒ€âãã€ã·ã³ã®ïŒ®âã¢ã«ãã«äœã«çœ®ãæ
ããããšã«éäžãããã
ä¿æããªãããååæ§é ã®å€æŽã«ãã€ãŠçµå£æŽ»æ§
åã³é·ãäœçšæéãæããååç©ãåŸãããšãè©Š
ã¿ãããããã®åªåã¯äžå€®ã«ããâãã€ã·ã³ã
âãã€ã·ã³ã«ïŒç±³åœç¹èš±4278595å·ïŒåã¯ïŒ¬â
ãããã¯ïŒ€âãã€ã·ã³ã®ïŒ®âã¢ã«ãã«äœã«çœ®ãæ
ããããšã«éäžãããã
âãããªã³ãé
žåã¯ã¢ããé
žã§çœ®æããããš
ã¯ã»ãšãã©è©Šã¿ãããªãã€ãããªããªãã°ïŒ¬âã
ãã°ã«ã¿ãã³é žã«çœ®ãæããããšãé€ããŠã¯ãã
ãã¯ç¡å®³ã§ãããïŒActa.Pharm.Suec.13å·»289é
ïŒ1976幎ïŒãè¬çåŠçã«äžæŽ»æ§ãªçæç©ã«å°ãã«ã
ããªãïŒJ.Med.Chem.21å·»165é 1978幎ïŒã
ã¯ã»ãšãã©è©Šã¿ãããªãã€ãããªããªãã°ïŒ¬âã
ãã°ã«ã¿ãã³é žã«çœ®ãæããããšãé€ããŠã¯ãã
ãã¯ç¡å®³ã§ãããïŒActa.Pharm.Suec.13å·»289é
ïŒ1976幎ïŒãè¬çåŠçã«äžæŽ»æ§ãªçæç©ã«å°ãã«ã
ããªãïŒJ.Med.Chem.21å·»165é 1978幎ïŒã
æ¬çºæè
ãã¯ã次åŒ
âNHâCR2R3âC0âNHâCH2âCOâR1
 ïŒåŒäžR1ã¯NH2åºãæå³ããR2åã³R3ã¯åäž
ã§ãç°ãªã€ãŠããããC1ãC5âã¢ã«ãã«åºãã
ãšãã«åºããã³ãžã«åºåã¯ãããã«åºãæå³ãã
åã¯ãããã«å ±éã®ççŽ ååãšäžç·ã«ïŒãïŒåã®
ççŽ ååãæããèèªæã®ç°ç³»ãæå³ããŠãã
ããåã¯ïŒïŒïŒâãããã¯ïŒïŒïŒâã€ã³ãã³ãžã€
ã«åºãæå³ããã¯ãããŒã«âïŒâã€ã«ã«ã«ãã
ã«åºãã€ã³ããŒã«âïŒâã€ã«ã«ã«ããã«åºãã·ã¯
ããã³ãã«ã«ã«ããã«åºãâãããªãžã³âïŒâ
ã€ã«ã«ã«ããã«åºãâïŒïŒïŒâãããããããª
ãžã³âïŒâã€ã«ã«ã«ããã«åºãâïŒâãªããœã
ããªãžã³âïŒâã€ã«ã«ã«ããã«åºãâïŒïŒïŒâ
ãã¢ãŸãªãžã³âïŒâã€ã«ã«ã«ããã«åºåã¯ïŒ¬â
ïŒïŒïŒâãã¢ã¶ã³âïŒâã€ã«ã«ã«ããã«åºãæå³
ããïŒã§è¡šããããããããã®ïŒ®âã¢ã·ã«èªå°
äœããªãã³ã«çççã«å®¹èªãããé žã«ãããã®å¡©
ãäžæ¢ç¥çµç³»ã«è¯å¥œã«äœçšããããšãèŠåºããã
 ïŒåŒäžR1ã¯NH2åºãæå³ããR2åã³R3ã¯åäž
ã§ãç°ãªã€ãŠããããC1ãC5âã¢ã«ãã«åºãã
ãšãã«åºããã³ãžã«åºåã¯ãããã«åºãæå³ãã
åã¯ãããã«å ±éã®ççŽ ååãšäžç·ã«ïŒãïŒåã®
ççŽ ååãæããèèªæã®ç°ç³»ãæå³ããŠãã
ããåã¯ïŒïŒïŒâãããã¯ïŒïŒïŒâã€ã³ãã³ãžã€
ã«åºãæå³ããã¯ãããŒã«âïŒâã€ã«ã«ã«ãã
ã«åºãã€ã³ããŒã«âïŒâã€ã«ã«ã«ããã«åºãã·ã¯
ããã³ãã«ã«ã«ããã«åºãâãããªãžã³âïŒâ
ã€ã«ã«ã«ããã«åºãâïŒïŒïŒâãããããããª
ãžã³âïŒâã€ã«ã«ã«ããã«åºãâïŒâãªããœã
ããªãžã³âïŒâã€ã«ã«ã«ããã«åºãâïŒïŒïŒâ
ãã¢ãŸãªãžã³âïŒâã€ã«ã«ã«ããã«åºåã¯ïŒ¬â
ïŒïŒïŒâãã¢ã¶ã³âïŒâã€ã«ã«ã«ããã«åºãæå³
ããïŒã§è¡šããããããããã®ïŒ®âã¢ã·ã«èªå°
äœããªãã³ã«çççã«å®¹èªãããé žã«ãããã®å¡©
ãäžæ¢ç¥çµç³»ã«è¯å¥œã«äœçšããããšãèŠåºããã
塩圢æã®ããã«ã¯ç¹ã«äžèšã®çççã«å®¹èªãã
ãé žãé©ãããå¡©é žãç¡«é žãçé žãé ¢é žãä¹³é žã
ãã¯ãé žãããã«é žåã³ãããé žã
ãé žãé©ãããå¡©é žãç¡«é žãçé žãé ¢é žãä¹³é žã
ãã¯ãé žãããã«é žåã³ãããé žã
R2ãšR3ãçžç°ãªããšãã¯ãåŒH2âCR2R3â
COOHã®åºçºç©è³ªã¯ã©ã»ãäœãšããŠååšããã
ããã¯å ¬ç¥æ¹æ³ã«ãã察æäœã«åå²ãããçŽç²ãª
âåã¯ïŒ¬âååç©ãšããŠåå¿ã«çšããããã
COOHã®åºçºç©è³ªã¯ã©ã»ãäœãšããŠååšããã
ããã¯å ¬ç¥æ¹æ³ã«ãã察æäœã«åå²ãããçŽç²ãª
âåã¯ïŒ¬âååç©ãšããŠåå¿ã«çšããããã
âOHãå
åŠæŽ»æ§ã®ã¢ããé
žã§ãããšãã¯ã
åŒH2âCR2R3âCOOHã®åºçºç©è³ªãããã®ã©
ã»ãäœã®åœ¢ã§åå¿ã«çšããããããããããšïŒçš®
ã®ç«äœç°æ§ããããã®æ··åç©ãåŸãããããã¯ã¯
ãããã°ã©ãã€åã¯çµæ¶åã«ããåé¢ã§ããã
åŒH2âCR2R3âCOOHã®åºçºç©è³ªãããã®ã©
ã»ãäœã®åœ¢ã§åå¿ã«çšããããããããããšïŒçš®
ã®ç«äœç°æ§ããããã®æ··åç©ãåŸãããããã¯ã¯
ãããã°ã©ãã€åã¯çµæ¶åã«ããåé¢ã§ããã
æ°èŠååç©ã¯ãåºçºç©è³ªã§ããâOHãH2
âCR2R3âCOOHåã³H2âCH2âCOâR1ïŒå
èšå·ã¯åèšã®æå³ãæããïŒããããããååŠã«
æ®éã®æ¹æ³ã§çž®åãããããšã«ãã補é ãããã
âCR2R3âCOOHåã³H2âCH2âCOâR1ïŒå
èšå·ã¯åèšã®æå³ãæããïŒããããããååŠã«
æ®éã®æ¹æ³ã§çž®åãããããšã«ãã補é ãããã
åæã¯ããŸãâOHãH2âCR2R3âCOOH
ãšçž®åããã次ãã§åŸãããååç©ãH2â
CH2âCOâR1ãšåå¿ããããããããã¯ãŸãH2
âCR2R3âCOOHãH2âCH2âCOâR1ãšçž®
åãããçæãããããããâOHãšåå¿ãã
ãããšã«ããè¡ããããåã ã®åå¿å·¥çšã¯ãåã
ã®å·¥çšã§åå¿ã«é¢äžããªãã¢ãã³æ©èœåã³é žæ©èœ
ãé©åœãªä¿è·åºã§å¡ãã ã®ã¡è¡ããããä¿è·åºã®
è±é¢ã¯åå¿åŸã«ãããããååŠã«ãããåžžæ³ã«ã
ãè¡ãããããã®æ¹æ³ã¯ã¡ããŒãã³ã»ãã«ã»ãªã«
ã¬ããã·ãšã³ã»ãããŒïŒïŒå·»åã³ïŒïŒå·»
1974幎çã«è©³ããèšèŒãããŠããã
ãšçž®åããã次ãã§åŸãããååç©ãH2â
CH2âCOâR1ãšåå¿ããããããããã¯ãŸãH2
âCR2R3âCOOHãH2âCH2âCOâR1ãšçž®
åãããçæãããããããâOHãšåå¿ãã
ãããšã«ããè¡ããããåã ã®åå¿å·¥çšã¯ãåã
ã®å·¥çšã§åå¿ã«é¢äžããªãã¢ãã³æ©èœåã³é žæ©èœ
ãé©åœãªä¿è·åºã§å¡ãã ã®ã¡è¡ããããä¿è·åºã®
è±é¢ã¯åå¿åŸã«ãããããååŠã«ãããåžžæ³ã«ã
ãè¡ãããããã®æ¹æ³ã¯ã¡ããŒãã³ã»ãã«ã»ãªã«
ã¬ããã·ãšã³ã»ãããŒïŒïŒå·»åã³ïŒïŒå·»
1974幎çã«è©³ããèšèŒãããŠããã
æ°èŠååç©ã®ããã«ã¯äžèšã®åææ³ãç¹ã«å¥œãŸ
ãããå Žåã«ããååšããNHåºããã³ãžã«ãªã
ã·ã«ã«ããã«åºåã¯ããã«ãªãã·ã«ã«ããã«åºã«
ããä¿è·ãããã«ã«ãã³é žïŒžâOHããæ¬¡åŒ H2âCR2R3âCOâOR6 ïŒR6ã¯ã¡ãã«åºåã¯ãšãã«åºãæå³ããïŒã®
ã¢ããé žãšã¹ãã«ãšåå¿ãããŠãæ¬¡åŒ ïŒžâNHâCR2R3âCOâOR6 ã®äžéçæç©ã«ããããã®ããã«ã¯äžè¬ã«ãã«ã«
ãã³é žïŒžâOHã®éé¢é žæ©èœããã¢ããé žèªå°äœ
ã«äœçšãããåã«æŽ»æ§åããããšãå¿ èŠã§ã
ããã«ã«ãã³é žã®æŽ»æ§èªå°äœãšããŠåªããŠããã
ã®ã¯æ··åç¡æ°Žç©ïŒããã¯ã¯ãã«çŸ©é žã¢ã«ãã«ãšã¹
ãã«äŸãã°ã¯ãã«çŸ©é žã€ãœããã«ãšã¹ãã«åã¯ã¯
ãã«çŸ©é žãšãã«ãšã¹ãã«ããã®å Žã§äœçšãããã
ãšã«ãã補é ãããïŒãã«ã«ããžã€ããïŒå¥œãŸã
ãã¯ãžã·ã¯ãããã·ã«ã«ã«ããžã€ããïŒãžã®ä»å
çæç©åã¯æŽ»æ§ãšã¹ãã«ïŒå¥œãŸããã¯ïŒ®âããã
ãã·ãã¯ãé žã€ããåã³ãžã·ã¯ãããã·ã«ã«ã«ã
ãžã€ããããå Žåã«ãããã®å Žã§è£œé ã§ããâ
ããããã·ãã¯ãé žã€ãããšã¹ãã«ïŒã§ããã掻
æ§èªå°äœã®çž®åã¯ãææ©æº¶å€äŸãã°ãžãªããµã³ã
ããã©ããããã©ã³ããžã¯ãã«ã¡ã¿ã³ãã¯ããã
ã«ã ããã«ãªãŒã«åã¯ãžã¡ãã«ãã«ã ã¢ããã®äž
ã§ããããã¯æ°Žâææ©åªè³ªäžã§å¡©åºã®ååšäžã«è¡
ããããå¡©åºãšããŠã¯ã奜ãŸããã¯ããªãšãã«ã¢
ãã³ãâã¡ãã«ã¢ã«ããªã³åã¯çé žæ°ŽçŽ ãããª
ãŠã ãçšãããããåå¿æž©åºŠã¯â10ãïŒ30âãå
å¿æéã¯ïŒæéãªããïŒæ¥ã§ããã
ãããå Žåã«ããååšããNHåºããã³ãžã«ãªã
ã·ã«ã«ããã«åºåã¯ããã«ãªãã·ã«ã«ããã«åºã«
ããä¿è·ãããã«ã«ãã³é žïŒžâOHããæ¬¡åŒ H2âCR2R3âCOâOR6 ïŒR6ã¯ã¡ãã«åºåã¯ãšãã«åºãæå³ããïŒã®
ã¢ããé žãšã¹ãã«ãšåå¿ãããŠãæ¬¡åŒ ïŒžâNHâCR2R3âCOâOR6 ã®äžéçæç©ã«ããããã®ããã«ã¯äžè¬ã«ãã«ã«
ãã³é žïŒžâOHã®éé¢é žæ©èœããã¢ããé žèªå°äœ
ã«äœçšãããåã«æŽ»æ§åããããšãå¿ èŠã§ã
ããã«ã«ãã³é žã®æŽ»æ§èªå°äœãšããŠåªããŠããã
ã®ã¯æ··åç¡æ°Žç©ïŒããã¯ã¯ãã«çŸ©é žã¢ã«ãã«ãšã¹
ãã«äŸãã°ã¯ãã«çŸ©é žã€ãœããã«ãšã¹ãã«åã¯ã¯
ãã«çŸ©é žãšãã«ãšã¹ãã«ããã®å Žã§äœçšãããã
ãšã«ãã補é ãããïŒãã«ã«ããžã€ããïŒå¥œãŸã
ãã¯ãžã·ã¯ãããã·ã«ã«ã«ããžã€ããïŒãžã®ä»å
çæç©åã¯æŽ»æ§ãšã¹ãã«ïŒå¥œãŸããã¯ïŒ®âããã
ãã·ãã¯ãé žã€ããåã³ãžã·ã¯ãããã·ã«ã«ã«ã
ãžã€ããããå Žåã«ãããã®å Žã§è£œé ã§ããâ
ããããã·ãã¯ãé žã€ãããšã¹ãã«ïŒã§ããã掻
æ§èªå°äœã®çž®åã¯ãææ©æº¶å€äŸãã°ãžãªããµã³ã
ããã©ããããã©ã³ããžã¯ãã«ã¡ã¿ã³ãã¯ããã
ã«ã ããã«ãªãŒã«åã¯ãžã¡ãã«ãã«ã ã¢ããã®äž
ã§ããããã¯æ°Žâææ©åªè³ªäžã§å¡©åºã®ååšäžã«è¡
ããããå¡©åºãšããŠã¯ã奜ãŸããã¯ããªãšãã«ã¢
ãã³ãâã¡ãã«ã¢ã«ããªã³åã¯çé žæ°ŽçŽ ãããª
ãŠã ãçšãããããåå¿æž©åºŠã¯â10ãïŒ30âãå
å¿æéã¯ïŒæéãªããïŒæ¥ã§ããã
ååç©ã®ãšã¹ãã«åºã¯ãæ°Žäžåã¯æ°Žâææ©åª
äœäžã§ãåœéã®åžã¢ã«ã«ãªãçšããŠïŒã40âã§
ïŒåå¿æéã¯ïŒæéãªããïŒæ¥ïŒåŠçããããšã«
ãããå æ°Žå解çã«åé¢ãããã
äœäžã§ãåœéã®åžã¢ã«ã«ãªãçšããŠïŒã40âã§
ïŒåå¿æéã¯ïŒæéãªããïŒæ¥ïŒåŠçããããšã«
ãããå æ°Žå解çã«åé¢ãããã
é
žæ§ã«ããŠå¯Ÿå¿ããä»äžãåŠçãè¡ã€ãã®ã¡ã
æ¬¡åŒ ïŒžâNHâCR2R3âCOâOH ã®ã«ã«ãã³é žãåŸããããããæ¬¡åŒ H2âCH2âCOâR1 ã®ã°ãªã·ã³èªå°äœãšåå¿ãããã
æ¬¡åŒ ïŒžâNHâCR2R3âCOâOH ã®ã«ã«ãã³é žãåŸããããããæ¬¡åŒ H2âCH2âCOâR1 ã®ã°ãªã·ã³èªå°äœãšåå¿ãããã
ãã®å Žåã¯äžè¬ã«ãã«ã«ãã³é
žã®éé¢é
žæ©èœ
ããã°ãªã·ã³èªå°äœã«äœçšãããåã«æŽ»æ§åãã
ããšãå¿ èŠã§ããããã®æŽ»æ§åã¯ãåèšæ¹æ³ã§æ··
åé žç¡æ°Žç©ãã«ã«ããžã€ããã®ä»å ç©åã¯æŽ»æ§ãš
ã¹ãã«ãçæããããšã«ããèµ·ããã
ããã°ãªã·ã³èªå°äœã«äœçšãããåã«æŽ»æ§åãã
ããšãå¿ èŠã§ããããã®æŽ»æ§åã¯ãåèšæ¹æ³ã§æ··
åé žç¡æ°Žç©ãã«ã«ããžã€ããã®ä»å ç©åã¯æŽ»æ§ãš
ã¹ãã«ãçæããããšã«ããèµ·ããã
ããããŠïŒžãçªçŽ ååã®å«æããªãåŒã®æ¬çº
æã®ååç©ãåŸãããããçªçŽ ååã®å«æãã
ãšãã¯ãããã«ä¿è·åºãè±é¢ããã°ãªããªããã
ãããã³ãžã«ãªãã·ã«ã«ããã«åºãªãã°ãè±é¢ã¯
äžæŽ»æ§æº¶å€äžã§è²Žéå±è§Šåªã®ååšäžã«å®€æž©ã§æ°ŽçŽ
åããããšã«ããè¡ãããã奜ãŸãã貎éå±è§Šåª
ã¯ãã©ãžãŠã ãçœéåã¯ã©ãâããã±ã«ã§ããã
奜ãŸããå®æœæ æ§ã«ãããŠã¯ãäŸãã°çæ«äžã®10
ïŒ ãã©ãžãŠã ãçšããããã溶å€ãšããŠã¯å¥œãŸã
ãã¯ã¡ã¿ããŒã«ãé ¢é žãšãã«åã¯æ°·é ¢é žãçšãã
ãããä¿è·åºãäžçŽããã«ãªãã·ã«ã«ããã«åºã§
ãããšãã¯ãè±é¢ã¯å¥œãŸããã¯éå°ã®ããªãã«ãª
ã«é ¢é žãçšããŠãåã¯äžæŽ»æ§ææ©æº¶å€äŸãã°é ¢é ž
ãšãã«ããžãªããµã³åã¯ããã©ããããã©ã³ã®äž
ã®å¡©åæ°ŽçŽ ã®æº¶æ¶²ãçšããŠè¡ããããè±é¢åå¿ã¯
ïŒã20âã§è¡ããããåå¿æéã¯ïŒã30åã§ã
ãã
æã®ååç©ãåŸãããããçªçŽ ååã®å«æãã
ãšãã¯ãããã«ä¿è·åºãè±é¢ããã°ãªããªããã
ãããã³ãžã«ãªãã·ã«ã«ããã«åºãªãã°ãè±é¢ã¯
äžæŽ»æ§æº¶å€äžã§è²Žéå±è§Šåªã®ååšäžã«å®€æž©ã§æ°ŽçŽ
åããããšã«ããè¡ãããã奜ãŸãã貎éå±è§Šåª
ã¯ãã©ãžãŠã ãçœéåã¯ã©ãâããã±ã«ã§ããã
奜ãŸããå®æœæ æ§ã«ãããŠã¯ãäŸãã°çæ«äžã®10
ïŒ ãã©ãžãŠã ãçšããããã溶å€ãšããŠã¯å¥œãŸã
ãã¯ã¡ã¿ããŒã«ãé ¢é žãšãã«åã¯æ°·é ¢é žãçšãã
ãããä¿è·åºãäžçŽããã«ãªãã·ã«ã«ããã«åºã§
ãããšãã¯ãè±é¢ã¯å¥œãŸããã¯éå°ã®ããªãã«ãª
ã«é ¢é žãçšããŠãåã¯äžæŽ»æ§ææ©æº¶å€äŸãã°é ¢é ž
ãšãã«ããžãªããµã³åã¯ããã©ããããã©ã³ã®äž
ã®å¡©åæ°ŽçŽ ã®æº¶æ¶²ãçšããŠè¡ããããè±é¢åå¿ã¯
ïŒã20âã§è¡ããããåå¿æéã¯ïŒã30åã§ã
ãã
æ°èŠãªãžããããã®ïŒ®âã¢ã·ã«èªå°äœã¯ãèçœ
åè§£é µçŽ ã®äœçšã«å¯Ÿãã»ãšãã©å®å®ã§ãçµå£æäž
ã§æå¹ã§ããããããŠé·ãæå¹æéãæããã
åè§£é µçŽ ã®äœçšã«å¯Ÿãã»ãšãã©å®å®ã§ãçµå£æäž
ã§æå¹ã§ããããããŠé·ãæå¹æéãæããã
æ°ç©è³ªã®åªè¶æ§ã¯ãç¹ã«äžèšã®ã¢ãã«è©Šéšã«ã
ã瀺ããããã¢ãã«è©ŠéšïŒåã³ïŒã¯æããŒãã³ãœ
ã³äœçšã蚌æããïŒã¯æ¬é¡çºæã®ç©è³ªã害ãªãã«
é©çšããããšãã§ããããšã瀺ãç©ççæ³äžã®ã
ã©ã¡ãŒã¿ãŒã§ãããã¢ãã«è©ŠéšïŒã¯æãã€äœçšã
蚌æããã
ã瀺ããããã¢ãã«è©ŠéšïŒåã³ïŒã¯æããŒãã³ãœ
ã³äœçšã蚌æããïŒã¯æ¬é¡çºæã®ç©è³ªã害ãªãã«
é©çšããããšãã§ããããšã瀺ãç©ççæ³äžã®ã
ã©ã¡ãŒã¿ãŒã§ãããã¢ãã«è©ŠéšïŒã¯æãã€äœçšã
蚌æããã
ïŒ ãšããŒã¬ããã»ãžãŒãšã ã«ããã°ïŒã¬ã©ãã
ã€ãåã³ããŠãŒã¯ãèã¢ã³ãããã¬ããµã³ãã»
ãã©ãã°ã¹1967幎164é 以äžïŒãâããŒãåã³
ããŒã®ãªã³ã®é åç©ïŒåŒ±ãè奮äœçšãæããïŒ
ãããŠã¹ã«äžãããäžæ¢åºæ¿æ§ç©è³ªã§ååŠçœ®ã
ãããšã«ããããŸãæçãªè奮ç¶æ ãèµ·ããã
ããæ°èŠãªããªããããã¯ãã®è©ŠéšäŸã«ãã
ãŠãçšé0.02mgïŒKgã®çµå£æäžã§æå¹ã§ããã
ã€ãåã³ããŠãŒã¯ãèã¢ã³ãããã¬ããµã³ãã»
ãã©ãã°ã¹1967幎164é 以äžïŒãâããŒãåã³
ããŒã®ãªã³ã®é åç©ïŒåŒ±ãè奮äœçšãæããïŒ
ãããŠã¹ã«äžãããäžæ¢åºæ¿æ§ç©è³ªã§ååŠçœ®ã
ãããšã«ããããŸãæçãªè奮ç¶æ ãèµ·ããã
ããæ°èŠãªããªããããã¯ãã®è©ŠéšäŸã«ãã
ãŠãçšé0.02mgïŒKgã®çµå£æäžã§æå¹ã§ããã
ïŒ ã³ãªã³äœçšå€ããã«ã«ãã³ãã©ããã«æäžã
ããšãæ«æ¢¢çç¶ã®ã»ãã«äžæ¢æ§ã²ã€ã€ããèµ·ã
ãïŒArch.exp.Path.Pharmak.247å·»317é 1964
幎ïŒãããã¯äžæ¢æ§æã³ãªã³äœçšå€ã«ãããã
ã ãäžæ¢æ§ã¢ãã¢ãã³åºæ¿å€ã«ãã€ãŠãé²æ¢ã§
ããïŒã¯ã©ã€ã¹ã³ããåã³ãããã³è6Int.
Congress.Pharmacol.ãã«ã·ã³ã1975幎
Abstr.825ïŒãæ¬çºæã®ããªããããã«ããçµå£
ååŠçœ®ã¯ãããã«ã«ãã³ã«ããèªå°ãããäžæ¢
æ§ã²ã€ãããæå¶ããã
ããšãæ«æ¢¢çç¶ã®ã»ãã«äžæ¢æ§ã²ã€ã€ããèµ·ã
ãïŒArch.exp.Path.Pharmak.247å·»317é 1964
幎ïŒãããã¯äžæ¢æ§æã³ãªã³äœçšå€ã«ãããã
ã ãäžæ¢æ§ã¢ãã¢ãã³åºæ¿å€ã«ãã€ãŠãé²æ¢ã§
ããïŒã¯ã©ã€ã¹ã³ããåã³ãããã³è6Int.
Congress.Pharmacol.ãã«ã·ã³ã1975幎
Abstr.825ïŒãæ¬çºæã®ããªããããã«ããçµå£
ååŠçœ®ã¯ãããã«ã«ãã³ã«ããèªå°ãããäžæ¢
æ§ã²ã€ãããæå¶ããã
ïŒ ã¢ãã«è©ŠéšïŒåã³ïŒã§æå¹ãªç©è³ªããããã«
ããŠã¹ã«ã€ããŠæå¹æ§åã³æ¯æ§ã調ã¹ãããã®
å Žåçç¶ãã¢ãŒãŽã€ã³ã®æ¹æ³ïŒãã·ã³ãã¢ã«ã
ã³ãã®ã¢13å·»222é 1968幎ïŒã«ããææ¡ããŠå®
éãããçš®ã ã®è©Šéšå åã«ã€ããŠãç©è³ªæäžã®
çŽåãªãã³ã«çµå£æäžã®1/2æéåŸãïŒæéåŸã
ïŒæéåŸåã³24æéåŸã«æž¬å®ãããåçšéããš
ã«ïŒå¹ã®åç©çŸ€ã䜿çšãããã¯ããã³ããã«éŠŽ
ããŠãã30ååŸã«ãæåã®æåè©Šéšãè¡ã€ãã
åºæ¬æåãäžæ¢åºæ¿åã³æž©åãªæå¶ãªãã³ã«èª
åŸç¥çµçç¶ãææ¡ãããåã ã«ã¯æ¬¡ã®ãã®ã§ã
ãã
ããŠã¹ã«ã€ããŠæå¹æ§åã³æ¯æ§ã調ã¹ãããã®
å Žåçç¶ãã¢ãŒãŽã€ã³ã®æ¹æ³ïŒãã·ã³ãã¢ã«ã
ã³ãã®ã¢13å·»222é 1968幎ïŒã«ããææ¡ããŠå®
éãããçš®ã ã®è©Šéšå åã«ã€ããŠãç©è³ªæäžã®
çŽåãªãã³ã«çµå£æäžã®1/2æéåŸãïŒæéåŸã
ïŒæéåŸåã³24æéåŸã«æž¬å®ãããåçšéããš
ã«ïŒå¹ã®åç©çŸ€ã䜿çšãããã¯ããã³ããã«éŠŽ
ããŠãã30ååŸã«ãæåã®æåè©Šéšãè¡ã€ãã
åºæ¬æåãäžæ¢åºæ¿åã³æž©åãªæå¶ãªãã³ã«èª
åŸç¥çµçç¶ãææ¡ãããåã ã«ã¯æ¬¡ã®ãã®ã§ã
ãã
身äœã®æå
åè¢ã®äœçœ®
æé€æå
æèæ··æ¿
èªçºåã³èªå°ã®æ©è¡æŽ»æ§
åŒåž
ç¥èŠéååå¿ïŒåå°ïŒ
çŒçŒéãå¹
ç³åã®å€§ãã
äœæž©ãã®ä»
æ°èŠç©è³ªã¯æ©è¡åã®äžæãªãã³ã«å¢åŒ·ããã
ããåããçŽç«åã³æé€åäœãèµ·ãããããã
ã®åŸ®åã¯ãããã³æ§æŽ»æ§åã³ãããã³åºæ¿æ§ã®
ç©è³ªã«ãããŠãåæ§ã«èµ·ããã
ããåããçŽç«åã³æé€åäœãèµ·ãããããã
ã®åŸ®åã¯ãããã³æ§æŽ»æ§åã³ãããã³åºæ¿æ§ã®
ç©è³ªã«ãããŠãåæ§ã«èµ·ããã
æ°èŠç©è³ªã¯ãããã€ãŠãããã³æ§çµéãæã
ãã«åºæ¿ãããã¢ãã«è©ŠéšïŒïŒïŒ¬âããŒã匷åïŒ
ã§ã¯ãå€çšãããã³ã®äœçšãå¢åŒ·ãããè©ŠéšïŒ
ïŒããã«ã«ãã³åºæ¿ïŒåã³è©ŠéšïŒïŒäœçšåïŒã§ã¯
å åšãããã³ããã®å¹æãå¢åŒ·ããã
ãã«åºæ¿ãããã¢ãã«è©ŠéšïŒïŒïŒ¬âããŒã匷åïŒ
ã§ã¯ãå€çšãããã³ã®äœçšãå¢åŒ·ãããè©ŠéšïŒ
ïŒããã«ã«ãã³åºæ¿ïŒåã³è©ŠéšïŒïŒäœçšåïŒã§ã¯
å åšãããã³ããã®å¹æãå¢åŒ·ããã
ïŒ äžçšåºŠã®çšéã®ã¢ã«ãã€ã³ã§ç®äžã«ååŠçœ®ã
ããã©ããã¯ãå šæåã«ã€ããŠã¯ç®ç«ããªãã
ãããè¿œå ã®å€éšåºæ¿ãå ãããšãäŸãã°å°Ÿã«
ã¯ãªãããã¯ãããšãã©ããã¯çªç¶ç¡¬ããªã€ãŠ
匷硬çãèµ·ãããåºæ¿ãé€ããšã©ããã¯åã³ç®
ç«ããªããªãïŒã¹ãã€ã«ã¬èããŒã«ã»ãã¢ã«ã
ã³ãã®ãŒã»ã«ã¿ããã²ãã«ã»ã·ãŠããã1971幎
30é åç §ïŒããã®åºæ¿ã«ããèªå°ãããç¶æ ã¯ã
æ¬çºæã®ããªããããã®éè泚å°ã«ãã€ãŠé²æ¢
ã§ããã
ããã©ããã¯ãå šæåã«ã€ããŠã¯ç®ç«ããªãã
ãããè¿œå ã®å€éšåºæ¿ãå ãããšãäŸãã°å°Ÿã«
ã¯ãªãããã¯ãããšãã©ããã¯çªç¶ç¡¬ããªã€ãŠ
匷硬çãèµ·ãããåºæ¿ãé€ããšã©ããã¯åã³ç®
ç«ããªããªãïŒã¹ãã€ã«ã¬èããŒã«ã»ãã¢ã«ã
ã³ãã®ãŒã»ã«ã¿ããã²ãã«ã»ã·ãŠããã1971幎
30é åç §ïŒããã®åºæ¿ã«ããèªå°ãããç¶æ ã¯ã
æ¬çºæã®ããªããããã®éè泚å°ã«ãã€ãŠé²æ¢
ã§ããã
ãããã€ãŠæ¬çºæã®ããããã¯åç¬ã§åã¯ïŒ¬â
ããŒããšçµã¿åãããŠãããŒãã³ãœã³ç åã³ããŒ
ãã³ãœã³æ§çç¶ãªãã³ã«ãã€ç ã®çµå£æ²»çã«é©ã
ããããã«ããã¯é¿çå€äŸåã®é²æ¢åã¯åŠçœ®ã«çš
ããããã
ããŒããšçµã¿åãããŠãããŒãã³ãœã³ç åã³ããŒ
ãã³ãœã³æ§çç¶ãªãã³ã«ãã€ç ã®çµå£æ²»çã«é©ã
ããããã«ããã¯é¿çå€äŸåã®é²æ¢åã¯åŠçœ®ã«çš
ããããã
æ¬çºæã®ååç©ã¯åžžæ³ã«ããçµå£çåã¯éçµå£
çïŒç®äžãéèå ãçèå ãè ¹è å ïŒã«æäžãã
ããšãã§ãããèžæ°åã¯åŽé§ãšããŠéŒ»è ã«é©çšã
ãããšãè¡ãããã
çïŒç®äžãéèå ãçèå ãè ¹è å ïŒã«æäžãã
ããšãã§ãããèžæ°åã¯åŽé§ãšããŠéŒ»è ã«é©çšã
ãããšãè¡ãããã
çšéã¯æ£è
ã®å¹Žä»€ãç¶æ
åã³äœéã«ããããªã
ã³ã«æäžåœ¢æ ã«ããç°ãªãããéåžžã¯ïŒæ¥ã®çšé
ã¯çµå£ã§äœéïŒKgã«ã€ãçŽ0.1ã100mgãéçµå£ã§
äœéïŒKgã«ã€ãçŽ0.01ã10mgã§ããã
ã³ã«æäžåœ¢æ ã«ããç°ãªãããéåžžã¯ïŒæ¥ã®çšé
ã¯çµå£ã§äœéïŒKgã«ã€ãçŽ0.1ã100mgãéçµå£ã§
äœéïŒKgã«ã€ãçŽ0.01ã10mgã§ããã
æ°èŠååç©ã¯åºåœ¢åã¯æ¶²ç¶ã®åžžçšã®ã¬ã¬ãã¹æ
äžåœ¢æ ãäŸãã°é å€ãèèé å€ãã«ãã»ã«å€ãæ£
å€ãé¡ç²å€ãç³è¡£é ã座å€ã溶液å€åã¯åŽé§å€ãš
ããŠçšããããããããã¯åžžæ³ã«ãã補é ãã
ããããªãã¡æå¹ç©è³ªãæ®éã®ã¬ã¬ãã¹å©å€ãäŸ
ãã°é å€çµåå€ã賊圢å€ãä¿åå€ãé å€åŽ©å£å€ã
æµåæ§èª¿æŽå€ãè»åå€ã湿最å€ãåæ£å€ãä¹³å
å€ã溶å€ãé 延å€ãæé žåå€åã³ïŒåã¯åŽå°ã¬ã¹
ãçšããŠå å·¥ããïŒãºãã«ãŒãèãã¢ã«ãããªã€
ãã€ãã·ãšã»ãã¯ããã®ãŒ1978幎çåç §ïŒããã
ããŠåŸããã補å€ã¯ãæå¹ç©è³ªãæ®éã¯0.1ã99
ééïŒ ã®éã§å«æããã
äžåœ¢æ ãäŸãã°é å€ãèèé å€ãã«ãã»ã«å€ãæ£
å€ãé¡ç²å€ãç³è¡£é ã座å€ã溶液å€åã¯åŽé§å€ãš
ããŠçšããããããããã¯åžžæ³ã«ãã補é ãã
ããããªãã¡æå¹ç©è³ªãæ®éã®ã¬ã¬ãã¹å©å€ãäŸ
ãã°é å€çµåå€ã賊圢å€ãä¿åå€ãé å€åŽ©å£å€ã
æµåæ§èª¿æŽå€ãè»åå€ã湿最å€ãåæ£å€ãä¹³å
å€ã溶å€ãé 延å€ãæé žåå€åã³ïŒåã¯åŽå°ã¬ã¹
ãçšããŠå å·¥ããïŒãºãã«ãŒãèãã¢ã«ãããªã€
ãã€ãã·ãšã»ãã¯ããã®ãŒ1978幎çåç §ïŒããã
ããŠåŸããã補å€ã¯ãæå¹ç©è³ªãæ®éã¯0.1ã99
ééïŒ ã®éã§å«æããã
å®éšã®éšïŒ
ãã¹ãŠã®åå¿ã®çµéã¯ãã·ãªã«ã²ã«è£œæ¿F254
ïŒã¡ã«ã¯ç€Ÿè£œïŒã䜿çšããèå±€ã¯ãããã°ã©ãã€
ã«ãã远跡ããããå±éå€ãšããŠã¯ãåŠçããã
ååç©ã®æ¥µæ§ã«ãã€ãŠããžã¯ãã«ã¡ã¿ã³ïŒã¢ã»ã
ã³20ïŒïŒãïŒïŒïŒããžã¯ãã«ã¡ã¿ã³ïŒã¡ã¿ããŒã«
20ïŒïŒãïŒïŒïŒåã¯ãã¿ããŒã«ïŒé ¢é žãšãã«ïŒæ°·
é ¢é žïŒæ°ŽïŒïŒïŒïŒïŒïŒïŒãçšããããã
ïŒã¡ã«ã¯ç€Ÿè£œïŒã䜿çšããèå±€ã¯ãããã°ã©ãã€
ã«ãã远跡ããããå±éå€ãšããŠã¯ãåŠçããã
ååç©ã®æ¥µæ§ã«ãã€ãŠããžã¯ãã«ã¡ã¿ã³ïŒã¢ã»ã
ã³20ïŒïŒãïŒïŒïŒããžã¯ãã«ã¡ã¿ã³ïŒã¡ã¿ããŒã«
20ïŒïŒãïŒïŒïŒåã¯ãã¿ããŒã«ïŒé ¢é žãšãã«ïŒæ°·
é ¢é žïŒæ°ŽïŒïŒïŒïŒïŒïŒïŒãçšããããã
äžèšã®å®æœäŸã«ããåŸãããæ°èŠååç©ã¯ãè
å±€ã¯ãããã°ã©ãã€ã«ããã°çŽç²ã§ãããNMR
ã¹ãã¯ãã«ã¯äžããããæ§é ãšäžèŽãããã»ã©ã€
ãã¯ãžãšã³ã¹ãŒãã³ãã«ç€Ÿã®éå©å€ã§ããã
å±€ã¯ãããã°ã©ãã€ã«ããã°çŽç²ã§ãããNMR
ã¹ãã¯ãã«ã¯äžããããæ§é ãšäžèŽãããã»ã©ã€
ãã¯ãžãšã³ã¹ãŒãã³ãã«ç€Ÿã®éå©å€ã§ããã
âåã¯ïŒ¬âïŒâã¡ãã«ãã€ã·ã³ã¡ãã«ãšã¹ã
ã«ã®è£œé ïŒ ã¡ã¿ããŒã«1170mläžã®ïŒ€ïŒïŒ¬âïŒâã¡ãã«ãã€
ã·ã³ã¡ãã«ãšã¹ãã«233.0gã®æº¶æ¶²ã«ãæ¹æããªã
ãïŒïŒïŒâé ç³é ž220.0ïœãæ·»å ãããâïŒâ
ã¡ãã«ãã€ã·ã³ã¡ãã«ãšã¹ãã«ã®é ç³é žå¡©ã®æåº
ã¯çæéåŸã«å§ãŸããæ²æ®¿ãå®çµããããïŒâã§
äžå€æŸçœ®ããã次ãã§æ²æ®¿ãéããå°éã®ã¡ã¿
ããŒã«ã§æŽæµããã¯ãããã«ã 1500mlãš10ïŒ çé ž
ãœãŒã溶液500mlãšã®éã§åé ãããæ°Žçžãã¯ã
ããã«ã ãçšããŠïŒåæœåºããäžç·ã«ããã¯ãã
ãã«ã æœåºæ¶²ã100mlã®æ°Žã§ïŒåæŽæµããç¡«é žã
ããªãŠã äžã§ä¹Ÿç¥ããã®ã¡ç空ã§èžçºããããαã
20 DïŒïŒâ20°ïŒïœïŒ1.0ãžã¯ãã«ã¡ã¿ã³ïŒã®ïŒ¬âïŒâ
ã¡ãã«ãã€ã·ã³ã¡ãã«ãšã¹ãã«ã78ïœïŒ34ïŒ ïŒåŸ
ãããã
ã«ã®è£œé ïŒ ã¡ã¿ããŒã«1170mläžã®ïŒ€ïŒïŒ¬âïŒâã¡ãã«ãã€
ã·ã³ã¡ãã«ãšã¹ãã«233.0gã®æº¶æ¶²ã«ãæ¹æããªã
ãïŒïŒïŒâé ç³é ž220.0ïœãæ·»å ãããâïŒâ
ã¡ãã«ãã€ã·ã³ã¡ãã«ãšã¹ãã«ã®é ç³é žå¡©ã®æåº
ã¯çæéåŸã«å§ãŸããæ²æ®¿ãå®çµããããïŒâã§
äžå€æŸçœ®ããã次ãã§æ²æ®¿ãéããå°éã®ã¡ã¿
ããŒã«ã§æŽæµããã¯ãããã«ã 1500mlãš10ïŒ çé ž
ãœãŒã溶液500mlãšã®éã§åé ãããæ°Žçžãã¯ã
ããã«ã ãçšããŠïŒåæœåºããäžç·ã«ããã¯ãã
ãã«ã æœåºæ¶²ã100mlã®æ°Žã§ïŒåæŽæµããç¡«é žã
ããªãŠã äžã§ä¹Ÿç¥ããã®ã¡ç空ã§èžçºããããαã
20 DïŒïŒâ20°ïŒïœïŒ1.0ãžã¯ãã«ã¡ã¿ã³ïŒã®ïŒ¬âïŒâ
ã¡ãã«ãã€ã·ã³ã¡ãã«ãšã¹ãã«ã78ïœïŒ34ïŒ ïŒåŸ
ãããã
âïŒâã¡ãã«ãã€ã·ã³ã¡ãã«ãšã¹ãã«ã®é
ç³
é žå¡©ã®æ¯æ¶²ãããåèšãšåæ§ã«ããŠå¡©åºãéé¢ã
ãïŒ130ïœïŒãããã«ã¡ã¿ããŒã«äžã§ïŒ€ïŒâïŒâé ç³
é ž122ïœãæ·»å ãããâïŒâã¡ãã«ãã€ã·ã³ã¡
ãã«ãšã¹ãã«ã®é ç³é žå¡©ãæ²æ®¿ãããããåèšãš
åæ§ã«ïŒ€âïŒâã¡ãã«ãã€ã·ã³ã¡ãã«ãšã¹ãã«ã«
ããïŒ68ïœã31ïŒ ïŒïŒãαã20 DïŒâ21°ïŒïœïŒ1.0ãžã¯
ãã«ã¡ã¿ã³ïŒã
é žå¡©ã®æ¯æ¶²ãããåèšãšåæ§ã«ããŠå¡©åºãéé¢ã
ãïŒ130ïœïŒãããã«ã¡ã¿ããŒã«äžã§ïŒ€ïŒâïŒâé ç³
é ž122ïœãæ·»å ãããâïŒâã¡ãã«ãã€ã·ã³ã¡
ãã«ãšã¹ãã«ã®é ç³é žå¡©ãæ²æ®¿ãããããåèšãš
åæ§ã«ïŒ€âïŒâã¡ãã«ãã€ã·ã³ã¡ãã«ãšã¹ãã«ã«
ããïŒ68ïœã31ïŒ ïŒïŒãαã20 DïŒâ21°ïŒïœïŒ1.0ãžã¯
ãã«ã¡ã¿ã³ïŒã
å®æœäŸ 1a
ãããŒã«âïŒâã€ã«ã«ã«ããã«ââïŒâã¡ã
ã«ãã€ã·ã«âã°ãªã·ã³ã¢ãã ãžãªããµã³200mläžã®ãããŒã«âïŒâã«ã«ãã³
é ž11.1ïœã«ã10âã§ãžã·ã¯ãããã·ã«ã«ã«ããžã€
ãã23.0ïœåã³ïŒ¬âïŒâã¡ãã«ãã€ã·ã³ã¡ãã«ãš
ã¹ãã«16.0gãæ·»å ãããåå¿æ··åç©ã10âã§ïŒ
æéã次ãã§å®€æž©ã§24æéæªæãããçæãããž
ã·ã¯ãããã·ã«å°¿çŽ ãéããã®ã¡ç空ã§èžçº
ããæ®çç©ãé ¢é žãšãã«äžã«ç§»ãã10ïŒ ãããé ž
氎溶液ãçé žãœãŒã溶液åã³æ°Žã§é 次æŽæµããç¡«
é žãããªãŠã äžã§ä¹Ÿç¥ããã®ã¡ç空ã§èžçºããã
ã·ãªã«ã²ã«ã«ã©ã ãçšããã¯ãããã°ã©ãã€ã«ã
ã粟補ãããšïŒãžã¯ãã«ã¡ã¿ã³ïŒé ¢é žãšãã«10ïŒ
ïŒã§æº¶åºïŒããããŒã«âïŒâã€ã«ã«ã«ããã«â
âïŒâã¡ãã«ãã€ã·ã³ã¡ãã«ãšã¹ãã«ã7.5ïœåŸ
ãããã
ã«ãã€ã·ã«âã°ãªã·ã³ã¢ãã ãžãªããµã³200mläžã®ãããŒã«âïŒâã«ã«ãã³
é ž11.1ïœã«ã10âã§ãžã·ã¯ãããã·ã«ã«ã«ããžã€
ãã23.0ïœåã³ïŒ¬âïŒâã¡ãã«ãã€ã·ã³ã¡ãã«ãš
ã¹ãã«16.0gãæ·»å ãããåå¿æ··åç©ã10âã§ïŒ
æéã次ãã§å®€æž©ã§24æéæªæãããçæãããž
ã·ã¯ãããã·ã«å°¿çŽ ãéããã®ã¡ç空ã§èžçº
ããæ®çç©ãé ¢é žãšãã«äžã«ç§»ãã10ïŒ ãããé ž
氎溶液ãçé žãœãŒã溶液åã³æ°Žã§é 次æŽæµããç¡«
é žãããªãŠã äžã§ä¹Ÿç¥ããã®ã¡ç空ã§èžçºããã
ã·ãªã«ã²ã«ã«ã©ã ãçšããã¯ãããã°ã©ãã€ã«ã
ã粟補ãããšïŒãžã¯ãã«ã¡ã¿ã³ïŒé ¢é žãšãã«10ïŒ
ïŒã§æº¶åºïŒããããŒã«âïŒâã€ã«ã«ã«ããã«â
âïŒâã¡ãã«ãã€ã·ã³ã¡ãã«ãšã¹ãã«ã7.5ïœåŸ
ãããã
ãžãªããµã³ïŒæ°ŽïŒïŒïŒïŒïŒ100mläžã®ãããŒã«
âïŒâã€ã«ã«ã«ããã«ââïŒâã¡ãã«ãã€ã·ã³
ã¡ãã«ãšã¹ãã«6.4ïœã«ã1Næ°Žé žåãããªãŠã 溶
液13mlã宀枩ã§æ·»å ããã24æéåŸã«ãžãªããµã³
ã®å€§éšåãç空ã§çå»ããæ®çç©ã«æ°Ž50mlãæ·»å
ããé ¢é žãšãã«ã§æ°åæœåºãããæ°Žçžããããé ž
ãæ·»å ããŠPHïŒãïŒãšãªããçæããã«ã«ãã³é ž
ãé ¢é žãšãã«ã§æœåºãããå°éã®æ°Žã§æŽæµããã®
ã¡ãç¡«é žãããªãŠã äžã§ä¹Ÿç¥ããç空ã§èžçºãã
ãšããããŒã«âïŒâã€ã«ã«ã«ããã«ââïŒâã¡
ãã«ãã€ã·ã³ã6.0ïœåŸãããã
âïŒâã€ã«ã«ã«ããã«ââïŒâã¡ãã«ãã€ã·ã³
ã¡ãã«ãšã¹ãã«6.4ïœã«ã1Næ°Žé žåãããªãŠã 溶
液13mlã宀枩ã§æ·»å ããã24æéåŸã«ãžãªããµã³
ã®å€§éšåãç空ã§çå»ããæ®çç©ã«æ°Ž50mlãæ·»å
ããé ¢é žãšãã«ã§æ°åæœåºãããæ°Žçžããããé ž
ãæ·»å ããŠPHïŒãïŒãšãªããçæããã«ã«ãã³é ž
ãé ¢é žãšãã«ã§æœåºãããå°éã®æ°Žã§æŽæµããã®
ã¡ãç¡«é žãããªãŠã äžã§ä¹Ÿç¥ããç空ã§èžçºãã
ãšããããŒã«âïŒâã€ã«ã«ã«ããã«ââïŒâã¡
ãã«ãã€ã·ã³ã6.0ïœåŸãããã
ããããžã¡ãã«ãã«ã ã¢ãã50mlåã³ããªãšã
ã«ã¢ãã³2.8mlã«æº¶è§£ããâ10âã§æªæããªããã¯
ãã«è»é žã€ãœããã«ãšã¹ãã«2.7mlã滎å ããã
åŸãããéå¯Ÿç§°é žç¡æ°Žç©ã®æº¶æ¶²ã«15ååŸã«ããžã¡
ãã«ãã«ã ã¢ãã10mläžã®ã°ãªã·ã³ã¢ããå¡©é žå¡©
3.3ïœåã³ããªãšãã«ã¢ãã³4.2mlãæ·»å ãããâ
10âã§ïŒæéã次ãã§å®€æž©ã§48æéæªæããã®
ã¡ãç空ã§èžçºãããæ®çç©ãé ¢é žãšãã«äžã«ç§»
ããææ©çžã10ïŒ ãããé žæ°Žæº¶æ¶²ãçé žãœãŒã溶
液åã³æ°Žã§é 次æŽæµããç¡«é žãããªãŠã äžã§ä¹Ÿç¥
ããã®ã¡ç空ã§èžçºãããæ®çç©ãã·ãªã«ã²ã«ã«
ã©ã ãçšããã¯ãããã°ã©ãã€ã«ããããšïŒãžã¯
ãã«ã¡ã¿ã³ïŒã¡ã¿ããŒã«ïŒïŒïŒã§æº¶åºïŒãèç¹113
ã128âïŒãžã¯ãã«ã¡ã¿ã³ïŒãšãŒãã«ïŒããαã20 DïŒ
ïŒ3°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒã®ãããŒã«âïŒâã€ã«
ã«ã«ããã«ââïŒâã¡ãã«ãã€ã·ã«âã°ãªã·ã³
ã¢ããã3.3ïœïŒ56ïŒ ïŒåŸãããã
ã«ã¢ãã³2.8mlã«æº¶è§£ããâ10âã§æªæããªããã¯
ãã«è»é žã€ãœããã«ãšã¹ãã«2.7mlã滎å ããã
åŸãããéå¯Ÿç§°é žç¡æ°Žç©ã®æº¶æ¶²ã«15ååŸã«ããžã¡
ãã«ãã«ã ã¢ãã10mläžã®ã°ãªã·ã³ã¢ããå¡©é žå¡©
3.3ïœåã³ããªãšãã«ã¢ãã³4.2mlãæ·»å ãããâ
10âã§ïŒæéã次ãã§å®€æž©ã§48æéæªæããã®
ã¡ãç空ã§èžçºãããæ®çç©ãé ¢é žãšãã«äžã«ç§»
ããææ©çžã10ïŒ ãããé žæ°Žæº¶æ¶²ãçé žãœãŒã溶
液åã³æ°Žã§é 次æŽæµããç¡«é žãããªãŠã äžã§ä¹Ÿç¥
ããã®ã¡ç空ã§èžçºãããæ®çç©ãã·ãªã«ã²ã«ã«
ã©ã ãçšããã¯ãããã°ã©ãã€ã«ããããšïŒãžã¯
ãã«ã¡ã¿ã³ïŒã¡ã¿ããŒã«ïŒïŒïŒã§æº¶åºïŒãèç¹113
ã128âïŒãžã¯ãã«ã¡ã¿ã³ïŒãšãŒãã«ïŒããαã20 DïŒ
ïŒ3°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒã®ãããŒã«âïŒâã€ã«
ã«ã«ããã«ââïŒâã¡ãã«ãã€ã·ã«âã°ãªã·ã³
ã¢ããã3.3ïœïŒ56ïŒ ïŒåŸãããã
åæ§ã«ããŠäžèšã®ååç©ãåŸãããã
1b ãããŒã«âïŒâã€ã«ã«ã«ããã«ââïŒâ
ã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ããïŒ48ïŒ ïŒãè
ç¹95ã125âïŒãžã¯ãã«ã¡ã¿ã³ïŒãšãŒãã«ïŒã
ãαã20 DïŒâ4°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 2a ã·ã¯ããã³ãã«âã«ã«ããã«ââïŒâã¡
ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ããïŒ59ïŒ ïŒãèç¹
125ã131âïŒã€ãœãããããŒã«ïŒãšãŒãã«ïŒã
ãαã20 DïŒâ12°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 2b ã·ã¯ããã³ãã«âã«ã«ããã«ââïŒâã¡
ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ããïŒ49ïŒ ïŒãèç¹
124ã130âïŒã€ãœãããããŒã«ïŒãšãŒãã«ïŒã
ãαã20 DïŒïŒ11°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 3a ã€ã³ããŒã«âïŒâã€ã«ã«ã«ããã«ââïŒ
âã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ããïŒ37ïŒ ïŒã
èç¹130ã140âïŒãžã¯ãã«ã¡ã¿ã³ïŒãšãŒãã«ïŒ
ãããµã³ïŒããαã20 DïŒïŒ11°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 3b ã€ã³ããŒã«âïŒâã€ã«ã«ã«ããã«ââïŒ
âã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ããïŒ45ïŒ ïŒã
èç¹120ã135âïŒãžã¯ãã«ã¡ã¿ã³ïŒãšãŒãã«ïŒ
ãããµã³ïŒããαã20 DïŒâ14°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ å®æœäŸ 4a âãããªã«ââïŒâã¡ãã«ãã€ã·ã«âã°ãª
ã·ã³ã¢ãã ãžã¡ãã«ãã«ã ã¢ãã90mläžã®ïŒ®âãã³ãžã«ãª
ãã·ã«ã«ããã«ââãããªã³13.7ïœåã³ããªãš
ãã«ã¢ãã³7.7mlã«ãâ10âã§ã¯ãã«è»é žã€ãœãã
ã«ãšã¹ãã«7.3mlã滎å ãããåŸãããéå¯Ÿç§°é ž
ç¡æ°Žç©ã®æº¶æ¶²ã«ã15ååŸã«ïŒ¬âïŒâã¡ãã«ãã€ã·
ã³ã¡ãã«ãšã¹ãã«8.8ïœãæ·»å ããâ10âã§ïŒæ
éã次ãã§å®€æž©ã§16æéæªæãããåå¿æ··åç©ã
é ¢é žãšãã«äžã«ç§»ããææ©çžã10ïŒ ãããé žæ°Žæº¶
液ãçé žãœãŒã溶液åã³æ°Žã§é 次æŽæµããç¡«é žã
ããªãŠã äžã§ä¹Ÿç¥ããã®ã¡ç空ã§èžçºãããšã
âãã³ãžã«ãªãã·ã«ã«ããã«ââãããªã«â
âïŒâã¡ãã«ãã€ã·ã³ã¡ãã«ãšã¹ãã«ã20.6ïœåŸ
ãããã
ã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ããïŒ48ïŒ ïŒãè
ç¹95ã125âïŒãžã¯ãã«ã¡ã¿ã³ïŒãšãŒãã«ïŒã
ãαã20 DïŒâ4°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 2a ã·ã¯ããã³ãã«âã«ã«ããã«ââïŒâã¡
ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ããïŒ59ïŒ ïŒãèç¹
125ã131âïŒã€ãœãããããŒã«ïŒãšãŒãã«ïŒã
ãαã20 DïŒâ12°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 2b ã·ã¯ããã³ãã«âã«ã«ããã«ââïŒâã¡
ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ããïŒ49ïŒ ïŒãèç¹
124ã130âïŒã€ãœãããããŒã«ïŒãšãŒãã«ïŒã
ãαã20 DïŒïŒ11°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 3a ã€ã³ããŒã«âïŒâã€ã«ã«ã«ããã«ââïŒ
âã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ããïŒ37ïŒ ïŒã
èç¹130ã140âïŒãžã¯ãã«ã¡ã¿ã³ïŒãšãŒãã«ïŒ
ãããµã³ïŒããαã20 DïŒïŒ11°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 3b ã€ã³ããŒã«âïŒâã€ã«ã«ã«ããã«ââïŒ
âã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ããïŒ45ïŒ ïŒã
èç¹120ã135âïŒãžã¯ãã«ã¡ã¿ã³ïŒãšãŒãã«ïŒ
ãããµã³ïŒããαã20 DïŒâ14°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ å®æœäŸ 4a âãããªã«ââïŒâã¡ãã«ãã€ã·ã«âã°ãª
ã·ã³ã¢ãã ãžã¡ãã«ãã«ã ã¢ãã90mläžã®ïŒ®âãã³ãžã«ãª
ãã·ã«ã«ããã«ââãããªã³13.7ïœåã³ããªãš
ãã«ã¢ãã³7.7mlã«ãâ10âã§ã¯ãã«è»é žã€ãœãã
ã«ãšã¹ãã«7.3mlã滎å ãããåŸãããéå¯Ÿç§°é ž
ç¡æ°Žç©ã®æº¶æ¶²ã«ã15ååŸã«ïŒ¬âïŒâã¡ãã«ãã€ã·
ã³ã¡ãã«ãšã¹ãã«8.8ïœãæ·»å ããâ10âã§ïŒæ
éã次ãã§å®€æž©ã§16æéæªæãããåå¿æ··åç©ã
é ¢é žãšãã«äžã«ç§»ããææ©çžã10ïŒ ãããé žæ°Žæº¶
液ãçé žãœãŒã溶液åã³æ°Žã§é 次æŽæµããç¡«é žã
ããªãŠã äžã§ä¹Ÿç¥ããã®ã¡ç空ã§èžçºãããšã
âãã³ãžã«ãªãã·ã«ã«ããã«ââãããªã«â
âïŒâã¡ãã«ãã€ã·ã³ã¡ãã«ãšã¹ãã«ã20.6ïœåŸ
ãããã
ããããžãªããµã³ïŒæ°ŽïŒïŒïŒïŒïŒ250mlã«å®€æž©
ã§æº¶è§£ããæ瀺è¬ãšããŠã®ãã¢ãŒã«ãã¿ã¬ã³ãçš
ããŠã¢ã«ã«ãªæ¶è²»ã調ç¯ããªããã1Næ°Žé žåã
ããªãŠã 溶液55mlãïŒmlãŸã§ã®å°éãã€çšããŠæª
æäžã«ããåãããåœéã®å¡©é žã§é žæ§ã«ããã®
ã¡ããžãªããµã³ã®å€§éšåãç空ã§çå»ãããæ®ç
ç©ãé ¢é žãšãã«äžã«ç§»ããåžçé žæ°ŽçŽ ã«ãªãŠã 溶
液ãçšããŠæœåºãããæ°Žæ§æœåºæ¶²ãé žæ§ã«ããã®
ã¡ãé ¢é žãšãã«ã§æ°åæœåºããæœåºæ¶²ãäžç·ã«ã
ãŠå°éã®æ°Žã§æŽæµããç¡«é žãããªãŠã äžã§ä¹Ÿç¥ã
ãã®ã¡ç空ã§èžçºãããšãâãã³ãžã«ãªãã·ã«
ã«ããã«ââãããªã«ââïŒâã¡ãã«ãã€ã·
ã³ã13.6ïœåŸãããã
ã§æº¶è§£ããæ瀺è¬ãšããŠã®ãã¢ãŒã«ãã¿ã¬ã³ãçš
ããŠã¢ã«ã«ãªæ¶è²»ã調ç¯ããªããã1Næ°Žé žåã
ããªãŠã 溶液55mlãïŒmlãŸã§ã®å°éãã€çšããŠæª
æäžã«ããåãããåœéã®å¡©é žã§é žæ§ã«ããã®
ã¡ããžãªããµã³ã®å€§éšåãç空ã§çå»ãããæ®ç
ç©ãé ¢é žãšãã«äžã«ç§»ããåžçé žæ°ŽçŽ ã«ãªãŠã 溶
液ãçšããŠæœåºãããæ°Žæ§æœåºæ¶²ãé žæ§ã«ããã®
ã¡ãé ¢é žãšãã«ã§æ°åæœåºããæœåºæ¶²ãäžç·ã«ã
ãŠå°éã®æ°Žã§æŽæµããç¡«é žãããªãŠã äžã§ä¹Ÿç¥ã
ãã®ã¡ç空ã§èžçºãããšãâãã³ãžã«ãªãã·ã«
ã«ããã«ââãããªã«ââïŒâã¡ãã«ãã€ã·
ã³ã13.6ïœåŸãããã
ãžã¡ãã«ãã«ã ã¢ãã50mläžã®ïŒ®âãã³ãžã«ãª
ãã·ã«ã«ããã«ââãããªã«ââïŒâã¡ãã«
ãã€ã·ã³11.3ïœåã³ããªãšãã«ã¢ãã³4.5mlã«ãâ
10âã§æ¹æããªããã¯ãã«è»é žã€ãœããã«ãšã¹ã
ã«3.9mlã滎å ãããåŸãããéå¯Ÿç§°é žç¡æ°Žç©ã®
溶液ã«ãâ10âã§æ¹æããªããã°ãªã·ã³ã¢ããå¡©
é žå¡©3.6ïœåã³ããªãšãã«ã¢ãã³4.6mlãæ·»å ãã
â10âã§ïŒæéã次ãã§å®€æž©ã§48æéæ¹æããã®
ã¡ç空ã§èžçºãããæ®çç©ãé ¢é žãšãã«äžã«ç§»
ããææ©çžã10ïŒ ãããé žæ°Žæº¶æ¶²ãçé žãœãŒã溶
液åã³æ°Žã§é 次æŽæµããç¡«é žãããªãŠã äžã§ä¹Ÿç¥
ããã®ã¡ç空ã§èžçºãããæ®çç©ãã·ãªã«ã²ã«ã«
ã©ã ãçšããã¯ãããã°ã©ãã€ïŒãžã¯ãã«ã¡ã¿
ã³ïŒã¡ã¿ããŒã«ïŒïŒïŒã§æº¶åºïŒã«ãã粟補ãã
ãšãâãã³ãžã«ãªãã·ã«ã«ããã«ââãããª
ã«ââïŒâã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ããã
6.6ïœåŸãããã
ãã·ã«ã«ããã«ââãããªã«ââïŒâã¡ãã«
ãã€ã·ã³11.3ïœåã³ããªãšãã«ã¢ãã³4.5mlã«ãâ
10âã§æ¹æããªããã¯ãã«è»é žã€ãœããã«ãšã¹ã
ã«3.9mlã滎å ãããåŸãããéå¯Ÿç§°é žç¡æ°Žç©ã®
溶液ã«ãâ10âã§æ¹æããªããã°ãªã·ã³ã¢ããå¡©
é žå¡©3.6ïœåã³ããªãšãã«ã¢ãã³4.6mlãæ·»å ãã
â10âã§ïŒæéã次ãã§å®€æž©ã§48æéæ¹æããã®
ã¡ç空ã§èžçºãããæ®çç©ãé ¢é žãšãã«äžã«ç§»
ããææ©çžã10ïŒ ãããé žæ°Žæº¶æ¶²ãçé žãœãŒã溶
液åã³æ°Žã§é 次æŽæµããç¡«é žãããªãŠã äžã§ä¹Ÿç¥
ããã®ã¡ç空ã§èžçºãããæ®çç©ãã·ãªã«ã²ã«ã«
ã©ã ãçšããã¯ãããã°ã©ãã€ïŒãžã¯ãã«ã¡ã¿
ã³ïŒã¡ã¿ããŒã«ïŒïŒïŒã§æº¶åºïŒã«ãã粟補ãã
ãšãâãã³ãžã«ãªãã·ã«ã«ããã«ââãããª
ã«ââïŒâã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ããã
6.6ïœåŸãããã
ãã®ååç©4.6ïœãã¡ã¿ããŒã«150mlã«æº¶è§£ãã
çæ«äžã®ãã©ãžãŠã ïŒ10ïŒ ïŒ0.5ïœã®ååšäžã«æ°Ž
çŽ åãããã»ã©ã€ãäžã§éãã液ãç空ã§èž
çºãããæ®çç©ããšãŒãã«äžã§æ©æŠããŠçµæ¶åã
ãããšãèç¹128ã132âïŒãšãŒãã«ïŒããαã20 DïŒ
â33°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒã®ïŒ¬âãããªã«â
âïŒâã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ããã2.7ïœ
åŸãããã
çæ«äžã®ãã©ãžãŠã ïŒ10ïŒ ïŒ0.5ïœã®ååšäžã«æ°Ž
çŽ åãããã»ã©ã€ãäžã§éãã液ãç空ã§èž
çºãããæ®çç©ããšãŒãã«äžã§æ©æŠããŠçµæ¶åã
ãããšãèç¹128ã132âïŒãšãŒãã«ïŒããαã20 DïŒ
â33°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒã®ïŒ¬âãããªã«â
âïŒâã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ããã2.7ïœ
åŸãããã
4b âãããªã«ââïŒâã¡ãã«ãã€ã·ã«â
ã°ãªã·ã³ã¢ããïŒ35ïŒ ïŒãèç¹155ã160âïŒãš
ãŒãã«ïŒãããµã³ïŒããαã20 DïŒâ37°ïŒïœïŒ0.5ã¡
ã¿ããŒã«ïŒ 5a âããã°ã«ã¿ãã«ââïŒâã¡ãã«ãã€
ã·ã«âã°ãªã·ã³ã¢ããïŒ23ïŒ ïŒãèç¹188ã191
âïŒã¡ã¿ããŒã«ïŒãšãŒãã«ïŒããαã20 DïŒâ4°ïŒïœ
ïŒ0.5ã¡ã¿ããŒã«ïŒ 5b âããã°ã«ã¿ãã«ââïŒâã¡ãã«ãã€
ã·ã«âã°ãªã·ã³ã¢ããïŒ23ïŒ ïŒãèç¹202ã204
âïŒãžã¯ãã«ã¡ã¿ã³ïŒãšãŒãã«ïŒããαã20 DïŒâ
25°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ å®æœäŸ 6a ïŒïŒïŒâããããââãããªã«ââïŒâã¡
ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ãã âããã«ãªãã·ã«ã«ããã«âïŒïŒïŒâããã
ãââãããªã³ããå®æœäŸ4aãšåæ§ã«ããŠã
âããã«ãªãã·ã«ã«ããã«âïŒïŒïŒâãããã
ââãããªã«ââïŒâã¡ãã«ãã€ã·ã«âã°ãª
ã·ã³ã¢ããã補é ãããä¿è·åºã®è±é¢ã¯äžèšã®ã
ãã«è¡ããããã«ãªãã·ã«ã«ããã«ååç©0.8ïœ
ãããžãªããµã³äžã®6Nå¡©åæ°ŽçŽ æº¶æ¶²15mlãçšã
ãŠå®€æž©ã§10åéåŠçããã次ãã§ç空ã§èžçºãã
æ®çç©ããã«ãªãŒã«ãšå ±ã«æ°åèžçºããã®ã¡ãã€
ãœãããããŒã«ïŒãšãŒãã«ããçµæ¶åãããšãè
ç¹137ã153âïŒã€ãœãããããŒã«ïŒãšãŒãã«ïŒã®
ïŒïŒïŒâããããââãããªã«ââïŒâã¡ã
ã«ãã€ã·ã«âã°ãªã·ã³ã¢ããã0.5ïœåŸãããã
ã°ãªã·ã³ã¢ããïŒ35ïŒ ïŒãèç¹155ã160âïŒãš
ãŒãã«ïŒãããµã³ïŒããαã20 DïŒâ37°ïŒïœïŒ0.5ã¡
ã¿ããŒã«ïŒ 5a âããã°ã«ã¿ãã«ââïŒâã¡ãã«ãã€
ã·ã«âã°ãªã·ã³ã¢ããïŒ23ïŒ ïŒãèç¹188ã191
âïŒã¡ã¿ããŒã«ïŒãšãŒãã«ïŒããαã20 DïŒâ4°ïŒïœ
ïŒ0.5ã¡ã¿ããŒã«ïŒ 5b âããã°ã«ã¿ãã«ââïŒâã¡ãã«ãã€
ã·ã«âã°ãªã·ã³ã¢ããïŒ23ïŒ ïŒãèç¹202ã204
âïŒãžã¯ãã«ã¡ã¿ã³ïŒãšãŒãã«ïŒããαã20 DïŒâ
25°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ å®æœäŸ 6a ïŒïŒïŒâããããââãããªã«ââïŒâã¡
ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ãã âããã«ãªãã·ã«ã«ããã«âïŒïŒïŒâããã
ãââãããªã³ããå®æœäŸ4aãšåæ§ã«ããŠã
âããã«ãªãã·ã«ã«ããã«âïŒïŒïŒâãããã
ââãããªã«ââïŒâã¡ãã«ãã€ã·ã«âã°ãª
ã·ã³ã¢ããã補é ãããä¿è·åºã®è±é¢ã¯äžèšã®ã
ãã«è¡ããããã«ãªãã·ã«ã«ããã«ååç©0.8ïœ
ãããžãªããµã³äžã®6Nå¡©åæ°ŽçŽ æº¶æ¶²15mlãçšã
ãŠå®€æž©ã§10åéåŠçããã次ãã§ç空ã§èžçºãã
æ®çç©ããã«ãªãŒã«ãšå ±ã«æ°åèžçºããã®ã¡ãã€
ãœãããããŒã«ïŒãšãŒãã«ããçµæ¶åãããšãè
ç¹137ã153âïŒã€ãœãããããŒã«ïŒãšãŒãã«ïŒã®
ïŒïŒïŒâããããââãããªã«ââïŒâã¡ã
ã«ãã€ã·ã«âã°ãªã·ã³ã¢ããã0.5ïœåŸãããã
åæ§ã«ããŠäžèšã®ååç©ãåŸãããã
6b ïŒïŒïŒâããããââãããªã«ââïŒ
âã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ããïŒ27ïŒ ïŒã
ãαã20 DïŒâ15°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 7a âïŒïŒïŒâãã¢ãŸãªãžã³âïŒâã€ã«ã«ã«
ããã«ââïŒâã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢
ããå¡©é žå¡©ãèç¹155ã165âïŒã¡ã¿ããŒã«ïŒãš
ãŒãã«ïŒããαã20 DïŒâ61°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 7b âïŒïŒïŒâãã¢ãŸãªãžã³âïŒâã€ã«ã«ã«
ããã«ââïŒâã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢
ããå¡©é žå¡©ãèç¹190ã200âïŒã¡ã¿ããŒã«ïŒãš
ãŒãã«ïŒããαã20 DïŒâ50°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 8a âïŒïŒïŒâãã¢ã¶ã³âïŒâã€ã«ã«ã«ãã
ã«ââïŒâã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ãã
å¡©é žå¡©ãèç¹184ã188âïŒã¡ã¿ããŒã«ïŒãšãŒã
ã«ïŒããαã20 DïŒïŒ13°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 8b âïŒïŒïŒâãã¢ã¶ã³âïŒâã€ã«ã«ã«ãã
ã«ââïŒâã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ãã
å¡©é žå¡©ãèç¹176ã181âïŒã¡ã¿ããŒã«ïŒãšãŒã
ã«ïŒããαã20 DïŒïŒ2°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ å®æœäŸ ïŒ ïŒ¬âãããªã«âïŒâã¢ããã·ã¯ããã³ãâïŒâ
ã€ã«ã«ã«ããã«âã°ãªã·ã³ã¢ãã ãžãªããµã³50mläžã®ïŒâã¢ããã·ã¯ããã³ã¿ã³
âïŒâã«ã«ãã³é žã¡ãã«ãšã¹ãã«5.6ïœã«ã10â
ã§ããªãšãã«ã¢ãã³5.4mlåã³ïŒ®âãã³ãžã«ãªã
ã·ã«ã«ããã«ââãããªã³ã®ïŒ®âããããã·ã
ã¯ãé žã€ãããšã¹ãã«13.5ïœãæ·»å ãããåå¿æ··
åç©ã10âã§ïŒæéæ¹æãã次ãã§æ°Ž20mlãå ã
ãŠå®€æž©ã§20æéåå¿ããããæ··åç©ãé ¢é žãšãã«
äžã«ç§»ããææ©çžã10ïŒ ãããé žæ°Žæº¶æ¶²ãçé žãœ
ãŒã溶液åã³æ°Žã§é 次æŽæµããç¡«é žãããªãŠã äž
ã§ä¹Ÿç¥ããã®ã¡ç空ã§èžçºãããåºäœæ®çç©ãçµ
æ¶åãããšãâãã³ãžã«ãªãã·ã«ã«ããã«â
âãããªã«âïŒâã¢ããã·ã¯ããã³ã¿ã³âïŒâã«
ã«ãã³é žã¡ãã«ãšã¹ãã«ã11.5ïœïŒ79ïŒ ïŒåŸãã
ãã
âã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ããïŒ27ïŒ ïŒã
ãαã20 DïŒâ15°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 7a âïŒïŒïŒâãã¢ãŸãªãžã³âïŒâã€ã«ã«ã«
ããã«ââïŒâã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢
ããå¡©é žå¡©ãèç¹155ã165âïŒã¡ã¿ããŒã«ïŒãš
ãŒãã«ïŒããαã20 DïŒâ61°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 7b âïŒïŒïŒâãã¢ãŸãªãžã³âïŒâã€ã«ã«ã«
ããã«ââïŒâã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢
ããå¡©é žå¡©ãèç¹190ã200âïŒã¡ã¿ããŒã«ïŒãš
ãŒãã«ïŒããαã20 DïŒâ50°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 8a âïŒïŒïŒâãã¢ã¶ã³âïŒâã€ã«ã«ã«ãã
ã«ââïŒâã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ãã
å¡©é žå¡©ãèç¹184ã188âïŒã¡ã¿ããŒã«ïŒãšãŒã
ã«ïŒããαã20 DïŒïŒ13°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 8b âïŒïŒïŒâãã¢ã¶ã³âïŒâã€ã«ã«ã«ãã
ã«ââïŒâã¡ãã«ãã€ã·ã«âã°ãªã·ã³ã¢ãã
å¡©é žå¡©ãèç¹176ã181âïŒã¡ã¿ããŒã«ïŒãšãŒã
ã«ïŒããαã20 DïŒïŒ2°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ å®æœäŸ ïŒ ïŒ¬âãããªã«âïŒâã¢ããã·ã¯ããã³ãâïŒâ
ã€ã«ã«ã«ããã«âã°ãªã·ã³ã¢ãã ãžãªããµã³50mläžã®ïŒâã¢ããã·ã¯ããã³ã¿ã³
âïŒâã«ã«ãã³é žã¡ãã«ãšã¹ãã«5.6ïœã«ã10â
ã§ããªãšãã«ã¢ãã³5.4mlåã³ïŒ®âãã³ãžã«ãªã
ã·ã«ã«ããã«ââãããªã³ã®ïŒ®âããããã·ã
ã¯ãé žã€ãããšã¹ãã«13.5ïœãæ·»å ãããåå¿æ··
åç©ã10âã§ïŒæéæ¹æãã次ãã§æ°Ž20mlãå ã
ãŠå®€æž©ã§20æéåå¿ããããæ··åç©ãé ¢é žãšãã«
äžã«ç§»ããææ©çžã10ïŒ ãããé žæ°Žæº¶æ¶²ãçé žãœ
ãŒã溶液åã³æ°Žã§é 次æŽæµããç¡«é žãããªãŠã äž
ã§ä¹Ÿç¥ããã®ã¡ç空ã§èžçºãããåºäœæ®çç©ãçµ
æ¶åãããšãâãã³ãžã«ãªãã·ã«ã«ããã«â
âãããªã«âïŒâã¢ããã·ã¯ããã³ã¿ã³âïŒâã«
ã«ãã³é žã¡ãã«ãšã¹ãã«ã11.5ïœïŒ79ïŒ ïŒåŸãã
ãã
åŸãããã¡ãã«ãšã¹ãã«8.2ïœãã¡ã¿ããŒã«100
mlã«æº¶è§£ãã1Næ°Žé žåãããªãŠã 溶液44mlãå
ããŠå®€æž©ã§20æéããåãããå¡©é žã§é žæ§ã«ãã
ã®ã¡ãç空ã§ã¡ã¿ããŒã«ãé€ãããèžçºæ¿çž®ãã
æ®ç氎溶液ãé ¢é žãšãã«ã§æœåºãããäžç·ã«ãã
æœåºæ¶²ãå°éã®æ°Žã§æŽæµããç¡«é žãããªãŠã äžã§
也ç¥ããã®ã¡èžçºãããæ®çç©ããã«ãªãŒã«ãšå ±
ã«æ°åèžçºãããšãâãã³ãžã«ãªãã·ã«ã«ãã
ã«ââãããªã«âïŒâã¢ããã·ã¯ããã³ã¿ã³â
ïŒâã«ã«ãã³é žã7.8ïœïŒçŽ100ïŒ ïŒåŸãããã
mlã«æº¶è§£ãã1Næ°Žé žåãããªãŠã 溶液44mlãå
ããŠå®€æž©ã§20æéããåãããå¡©é žã§é žæ§ã«ãã
ã®ã¡ãç空ã§ã¡ã¿ããŒã«ãé€ãããèžçºæ¿çž®ãã
æ®ç氎溶液ãé ¢é žãšãã«ã§æœåºãããäžç·ã«ãã
æœåºæ¶²ãå°éã®æ°Žã§æŽæµããç¡«é žãããªãŠã äžã§
也ç¥ããã®ã¡èžçºãããæ®çç©ããã«ãªãŒã«ãšå ±
ã«æ°åèžçºãããšãâãã³ãžã«ãªãã·ã«ã«ãã
ã«ââãããªã«âïŒâã¢ããã·ã¯ããã³ã¿ã³â
ïŒâã«ã«ãã³é žã7.8ïœïŒçŽ100ïŒ ïŒåŸãããã
ãžã¡ãã«ãã«ã ã¢ãã30mläžã®ãã®ååç©7.7
ïœåã³ããªãšãã«ã¢ãã³2.9mlã«ãâ10âã§æ¹æã
ãªããã¯ãã«è»é žã€ãœããã«ãšã¹ãã«2.7mlã滎
å ãããåŸãããéå¯Ÿç§°é žç¡æ°Žç©ã®æº¶æ¶²ã«15ååŸ
ã«ããžã¡ãã«ãã«ã ã¢ãã20mläžã®ã°ãªã·ã³ã¢ã
ãå¡©é žå¡©2.3ïœåã³ããªãšãã«ã¢ãã³2.9mlãæ·»å
ããâ10âãïŒâã§ïŒæéã次ãã§å®€æž©ã§48æé
æ¹æãããä»äžãåŠçã®ããæ··åç©ãé ¢é žãšãã«
äžã«ç§»ãã10ïŒ ãããé žæ°Žæº¶æ¶²ãçé žãœãŒã溶液
åã³æ°Žã§é 次æŽæµããç¡«é žãããªãŠã äžã§ä¹Ÿç¥ã
ãã®ã¡ç空ã§èžçºãããã·ãªã«ã²ã«äžã§ç²Ÿè£œã
ïŒãžã¯ãã«ã¡ã¿ã³ïŒã¡ã¿ããŒã«15ïŒïŒã§æº¶åºïŒã次
ãã§é ¢é žãšãã«ïŒãã«ãªãŒã«ããçµæ¶åãããšã
âãã³ãžã«ãªãã·ã«ã«ããã«ââãããªã«â
ïŒâã¢ããã·ã¯ããã³ãâïŒâã€ã«ã«ã«ããã«â
ã°ãªã·ã³ã¢ããã5.0ïœïŒ75ïŒ ïŒåŸãããã
ïœåã³ããªãšãã«ã¢ãã³2.9mlã«ãâ10âã§æ¹æã
ãªããã¯ãã«è»é žã€ãœããã«ãšã¹ãã«2.7mlã滎
å ãããåŸãããéå¯Ÿç§°é žç¡æ°Žç©ã®æº¶æ¶²ã«15ååŸ
ã«ããžã¡ãã«ãã«ã ã¢ãã20mläžã®ã°ãªã·ã³ã¢ã
ãå¡©é žå¡©2.3ïœåã³ããªãšãã«ã¢ãã³2.9mlãæ·»å
ããâ10âãïŒâã§ïŒæéã次ãã§å®€æž©ã§48æé
æ¹æãããä»äžãåŠçã®ããæ··åç©ãé ¢é žãšãã«
äžã«ç§»ãã10ïŒ ãããé žæ°Žæº¶æ¶²ãçé žãœãŒã溶液
åã³æ°Žã§é 次æŽæµããç¡«é žãããªãŠã äžã§ä¹Ÿç¥ã
ãã®ã¡ç空ã§èžçºãããã·ãªã«ã²ã«äžã§ç²Ÿè£œã
ïŒãžã¯ãã«ã¡ã¿ã³ïŒã¡ã¿ããŒã«15ïŒïŒã§æº¶åºïŒã次
ãã§é ¢é žãšãã«ïŒãã«ãªãŒã«ããçµæ¶åãããšã
âãã³ãžã«ãªãã·ã«ã«ããã«ââãããªã«â
ïŒâã¢ããã·ã¯ããã³ãâïŒâã€ã«ã«ã«ããã«â
ã°ãªã·ã³ã¢ããã5.0ïœïŒ75ïŒ ïŒåŸãããã
ãããã¡ã¿ããŒã«100mlã«æº¶è§£ããçæ«äžã®ã
ã©ãžãŠã ïŒ10ïŒ ïŒ0.5ïœã®ååšäžã«æ°ŽçŽ åããã
çè«éã®æ°ŽçŽ ãåžåãããã®ã¡ã»ã©ã€ãäžã§é
ãã液ãç空ã§èžçºããæ®çç©ãã€ãœãããã
ãŒã«åã³ãšãŒãã«ããçµæ¶åãããšãèç¹167ã
168âïŒã€ãœãããããŒã«ïŒãšãŒãã«ïŒã®ïŒ¬âã
ããªã«âïŒâã¢ããã·ã¯ããã³ãâïŒâã€ã«ã«ã«
ããã«âã°ãªã·ã³ã¢ããã2.9ïœïŒ86ïŒ ïŒåŸãã
ãã
ã©ãžãŠã ïŒ10ïŒ ïŒ0.5ïœã®ååšäžã«æ°ŽçŽ åããã
çè«éã®æ°ŽçŽ ãåžåãããã®ã¡ã»ã©ã€ãäžã§é
ãã液ãç空ã§èžçºããæ®çç©ãã€ãœãããã
ãŒã«åã³ãšãŒãã«ããçµæ¶åãããšãèç¹167ã
168âïŒã€ãœãããããŒã«ïŒãšãŒãã«ïŒã®ïŒ¬âã
ããªã«âïŒâã¢ããã·ã¯ããã³ãâïŒâã€ã«ã«ã«
ããã«âã°ãªã·ã³ã¢ããã2.9ïœïŒ86ïŒ ïŒåŸãã
ãã
åæ§ã«ããŠäžèšã®ååç©ãåŸãããã
10 âãããªã«âïŒâã¢ããã·ã¯ããããâïŒ
âã€ã«ã«ã«ããã«âã°ãªã·ã³ã¢ããïŒ15ïŒ ïŒã
ãαã20 DïŒâ37°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 11 âãããªã«âïŒâã¢ããã·ã¯ãããâïŒâ
ã€ã«ã«ã«ããã«âã°ãªã·ã³ã¢ããïŒ40ïŒ ïŒã
ãαã20 DïŒâ39°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 12 âãããªã«âïŒâã¢ããã·ã¯ãããã·âïŒ
âã€ã«ã«ã«ããã«âã°ãªã·ã³ã¢ããïŒ36ïŒ ïŒã
èç¹143ã146âïŒã€ãœãããããŒã«ïŒãšãŒã
ã«ïŒãããµã³ïŒããαã20 DïŒâ36°ïŒïœïŒ0.6ã¡ã¿ã
ãŒã«ïŒ 13 âãããªã«âïŒâã¢ããã·ã¯ããããâïŒ
âã€ã«ã«ã«ããã«âã°ãªã·ã³ã¢ããïŒ31ïŒ ïŒã
èç¹170ã174âïŒã€ãœãããããŒã«ïŒãšãŒã
ã«ïŒ 14 âãããªã«âïŒâã¢ããã€ã³ãã³âïŒâã€
ã«ã«ã«ããã«âã°ãªã·ã³ã¢ããïŒ29ïŒ ïŒãèç¹
178ã181âïŒé ¢é žãšãã«ïŒããαã20 DïŒâ38°ïŒïœ
ïŒ0.5ã¡ã¿ããŒã«ïŒ å®æœäŸ 15 âãããªã«ââïŒâã¢ããã€ã³ãã³âïŒâ
ã€ã«ã«ã«ããã«âã°ãªã·ã³ã¢ããåã³ïŒ¬âãã
ãªã«ââïŒâã¢ããã€ã³ãã³âïŒâã€ã«ã«ã«
ããã«âã°ãªã·ã³ã¢ãã ãžãªããµã³80mläžã®ïŒâã¢ããã€ã³ãã³âïŒâ
ã«ã«ãã³é žã¡ãã«ãšã¹ãã«13.4gã«ã10âã§ããª
ãšãã«ã¢ãã³11.4mlåã³ïŒ®âãã³ãžã«ãªãã·ã«ã«
ããã«ââãããªã³ã®ïŒ®âããããã·ãã¯ãé ž
ã€ãããšã¹ãã«26.0ïœãæ·»å ãããåå¿æ··åç©ã
10âã§ïŒæéæ¹æããã®ã¡ãæ°Ž15mlãæ·»å ããŠå®€
æž©ã§18æéåå¿ããããæ··åç©ãé ¢é žãšãã«äžã«
移ããææ©çžã10ïŒ ãããé žæ°Žæº¶æ¶²ãçé žãœãŒã
溶液åã³æ°Žã§é 次æŽæµããç¡«é žãããªãŠã äžã§ä¹Ÿ
ç¥ããã®ã¡ç空ã§èžçºãããšãâãã³ãžã«ãªã
ã·ã«ã«ããã«ââãããªã«âïŒïŒ¬âïŒâã¢ã
ãã€ã³ãã³âïŒâã«ã«ãã³é žã®ç²è£œã¡ãã«ãšã¹ã
ã«ã20.5ïœïŒ74ïŒ ïŒåŸãããã
âã€ã«ã«ã«ããã«âã°ãªã·ã³ã¢ããïŒ15ïŒ ïŒã
ãαã20 DïŒâ37°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 11 âãããªã«âïŒâã¢ããã·ã¯ãããâïŒâ
ã€ã«ã«ã«ããã«âã°ãªã·ã³ã¢ããïŒ40ïŒ ïŒã
ãαã20 DïŒâ39°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 12 âãããªã«âïŒâã¢ããã·ã¯ãããã·âïŒ
âã€ã«ã«ã«ããã«âã°ãªã·ã³ã¢ããïŒ36ïŒ ïŒã
èç¹143ã146âïŒã€ãœãããããŒã«ïŒãšãŒã
ã«ïŒãããµã³ïŒããαã20 DïŒâ36°ïŒïœïŒ0.6ã¡ã¿ã
ãŒã«ïŒ 13 âãããªã«âïŒâã¢ããã·ã¯ããããâïŒ
âã€ã«ã«ã«ããã«âã°ãªã·ã³ã¢ããïŒ31ïŒ ïŒã
èç¹170ã174âïŒã€ãœãããããŒã«ïŒãšãŒã
ã«ïŒ 14 âãããªã«âïŒâã¢ããã€ã³ãã³âïŒâã€
ã«ã«ã«ããã«âã°ãªã·ã³ã¢ããïŒ29ïŒ ïŒãèç¹
178ã181âïŒé ¢é žãšãã«ïŒããαã20 DïŒâ38°ïŒïœ
ïŒ0.5ã¡ã¿ããŒã«ïŒ å®æœäŸ 15 âãããªã«ââïŒâã¢ããã€ã³ãã³âïŒâ
ã€ã«ã«ã«ããã«âã°ãªã·ã³ã¢ããåã³ïŒ¬âãã
ãªã«ââïŒâã¢ããã€ã³ãã³âïŒâã€ã«ã«ã«
ããã«âã°ãªã·ã³ã¢ãã ãžãªããµã³80mläžã®ïŒâã¢ããã€ã³ãã³âïŒâ
ã«ã«ãã³é žã¡ãã«ãšã¹ãã«13.4gã«ã10âã§ããª
ãšãã«ã¢ãã³11.4mlåã³ïŒ®âãã³ãžã«ãªãã·ã«ã«
ããã«ââãããªã³ã®ïŒ®âããããã·ãã¯ãé ž
ã€ãããšã¹ãã«26.0ïœãæ·»å ãããåå¿æ··åç©ã
10âã§ïŒæéæ¹æããã®ã¡ãæ°Ž15mlãæ·»å ããŠå®€
æž©ã§18æéåå¿ããããæ··åç©ãé ¢é žãšãã«äžã«
移ããææ©çžã10ïŒ ãããé žæ°Žæº¶æ¶²ãçé žãœãŒã
溶液åã³æ°Žã§é 次æŽæµããç¡«é žãããªãŠã äžã§ä¹Ÿ
ç¥ããã®ã¡ç空ã§èžçºãããšãâãã³ãžã«ãªã
ã·ã«ã«ããã«ââãããªã«âïŒïŒ¬âïŒâã¢ã
ãã€ã³ãã³âïŒâã«ã«ãã³é žã®ç²è£œã¡ãã«ãšã¹ã
ã«ã20.5ïœïŒ74ïŒ ïŒåŸãããã
ããããžãªããµã³300mlã«æº¶è§£ãã4Næ°Žé
žåã
ããªãŠã 溶液18.0mlãå ããŠå®€æž©ã§ããåããã
åžå¡©é žã§é žæ§ã«ããã®ã¡ãç空ã§ãžãªããµã³ã倧
éšåèžçºé€å»ããæ®çç©ãé ¢é žãšãã«äžã«ç§»ãã
ææ©çžãçé žæ°ŽçŽ ã«ãªãŠã 溶液ãçšããŠæœåºã
ããäžç·ã«ããæ°Žæœåºæ¶²ãå¡©é žã§é žæ§ã«ããã®
ã¡ãé ¢é žãšãã«ã§æœåºããæœåºæ¶²ã也ç¥ããã®ã¡
ç空ã§èžçºãããšãâãã³ãžã«ãªãã·ã«ã«ãã
ã«ââãããªã«âïŒïŒ¬âïŒâã¢ããã€ã³ãã³
âïŒâã«ã«ãã³é žã11.0ïœïŒçŽ55ïŒ ïŒåŸãããã
ããªãŠã 溶液18.0mlãå ããŠå®€æž©ã§ããåããã
åžå¡©é žã§é žæ§ã«ããã®ã¡ãç空ã§ãžãªããµã³ã倧
éšåèžçºé€å»ããæ®çç©ãé ¢é žãšãã«äžã«ç§»ãã
ææ©çžãçé žæ°ŽçŽ ã«ãªãŠã 溶液ãçšããŠæœåºã
ããäžç·ã«ããæ°Žæœåºæ¶²ãå¡©é žã§é žæ§ã«ããã®
ã¡ãé ¢é žãšãã«ã§æœåºããæœåºæ¶²ã也ç¥ããã®ã¡
ç空ã§èžçºãããšãâãã³ãžã«ãªãã·ã«ã«ãã
ã«ââãããªã«âïŒïŒ¬âïŒâã¢ããã€ã³ãã³
âïŒâã«ã«ãã³é žã11.0ïœïŒçŽ55ïŒ ïŒåŸãããã
ãžã¡ãã«ãã«ã ã¢ãã30mläžã®ãã®ååç©10.2
ïœåã³ããªãšãã«ã¢ãã³3.8mlã«ãâ10âã§æ¹æã
ãªããã¯ãã«è»é žã€ãœããã«ãšã¹ãã«3.5mlã滎
å ãããåŸãããéå¯Ÿç§°é žç¡æ°Žç©ã«10ååŸã«ããž
ã¡ãã«ãã«ã ã¢ãã30mläžã®ã°ãªã·ã³ã¢ããå¡©é ž
å¡©3.0ïœã®æžæ¿æ¶²åã³ããªãšãã«ã¢ãã³3.8mlãæ·»
å ããâ10ãïŒâã§ïŒæéã次ãã§å®€æž©ã§48æé
æ¹æãããä»äžãåŠçã®ããæ··åç©ãé ¢é žãšãã«
äžã«ç§»ãã10ïŒ ãããé žæ°Žæº¶æ¶²ãçé žãœãŒã溶液
åã³æ°Žã§é 次æŽæµããç¡«é žãããªãŠã äžã§ä¹Ÿç¥ã
ãã®ã¡ç空ã§èžçºãããæ®çç©ãã·ãªã«ã²ã«ãçš
ããã¯ãããã°ã©ãã€ã«ããããšïŒãžã¯ãã«ã¡ã¿
ã³ïŒã¡ã¿ããŒã«20ïŒïŒã§æº¶åºïŒãæå 床ãäžæã
ãé åºã§äžèšã®äž¡ç°æ§äœãçŽç²ãªåœ¢ã§åŸãããã
ïœåã³ããªãšãã«ã¢ãã³3.8mlã«ãâ10âã§æ¹æã
ãªããã¯ãã«è»é žã€ãœããã«ãšã¹ãã«3.5mlã滎
å ãããåŸãããéå¯Ÿç§°é žç¡æ°Žç©ã«10ååŸã«ããž
ã¡ãã«ãã«ã ã¢ãã30mläžã®ã°ãªã·ã³ã¢ããå¡©é ž
å¡©3.0ïœã®æžæ¿æ¶²åã³ããªãšãã«ã¢ãã³3.8mlãæ·»
å ããâ10ãïŒâã§ïŒæéã次ãã§å®€æž©ã§48æé
æ¹æãããä»äžãåŠçã®ããæ··åç©ãé ¢é žãšãã«
äžã«ç§»ãã10ïŒ ãããé žæ°Žæº¶æ¶²ãçé žãœãŒã溶液
åã³æ°Žã§é 次æŽæµããç¡«é žãããªãŠã äžã§ä¹Ÿç¥ã
ãã®ã¡ç空ã§èžçºãããæ®çç©ãã·ãªã«ã²ã«ãçš
ããã¯ãããã°ã©ãã€ã«ããããšïŒãžã¯ãã«ã¡ã¿
ã³ïŒã¡ã¿ããŒã«20ïŒïŒã§æº¶åºïŒãæå 床ãäžæã
ãé åºã§äžèšã®äž¡ç°æ§äœãçŽç²ãªåœ¢ã§åŸãããã
âãã³ãžã«ãªãã·ã«ã«ããã«ââãããªã«
ââïŒâã¢ããã€ã³ãã³âïŒâã€ã«ã«ã«ããã«
âã°ãªã·ã³ã¢ãã3.9ïœïŒ34ïŒ ïŒåã³ïŒ®âãã³ãž
ã«ãªãã·ã«ã«ããã«ââãããªã«ââïŒâã¢
ããã€ã³ãã³âïŒâã€ã«ã«ã«ããã«âã°ãªã·ã³ã¢
ãã0.8ïœïŒïŒïŒ ïŒã
ââïŒâã¢ããã€ã³ãã³âïŒâã€ã«ã«ã«ããã«
âã°ãªã·ã³ã¢ãã3.9ïœïŒ34ïŒ ïŒåã³ïŒ®âãã³ãž
ã«ãªãã·ã«ã«ããã«ââãããªã«ââïŒâã¢
ããã€ã³ãã³âïŒâã€ã«ã«ã«ããã«âã°ãªã·ã³ã¢
ãã0.8ïœïŒïŒïŒ ïŒã
âãã³ãžã«ãªãã·ã«ã«ããã«ââãããªã«
ââïŒâã¢ããã€ã³ãã³âïŒâã€ã«ã«ã«ããã«
âã°ãªã·ã³ã¢ãã3.7ïœãã¡ã¿ããŒã«250mlã«æº¶è§£
ããçæ«äžã®ãã©ãžãŠã ïŒ10ïŒ ïŒ0.5ïœã®ååšäž
ã«æ°ŽçŽ åãããçè«éã®æ°ŽçŽ ãåžåãããã®ã¡ã
æ··åç©ãã»ã©ã€ãäžã§éãã液ãç空ã§èžçº
ããæ®çç©ãé ¢é žãšãã«ïŒç³æ²¹ãšãŒãã«ããçµæ¶
åãããšããαã20 DïŒâ86°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒã®
âãããªã«ââïŒâã¢ããã€ã³ãã³âïŒâã€
ã«ã«ã«ããã«âã°ãªã·ã³ã¢ããïŒ15bïŒã2.1ïœ
ïŒ83ïŒ ïŒåŸãããã
ââïŒâã¢ããã€ã³ãã³âïŒâã€ã«ã«ã«ããã«
âã°ãªã·ã³ã¢ãã3.7ïœãã¡ã¿ããŒã«250mlã«æº¶è§£
ããçæ«äžã®ãã©ãžãŠã ïŒ10ïŒ ïŒ0.5ïœã®ååšäž
ã«æ°ŽçŽ åãããçè«éã®æ°ŽçŽ ãåžåãããã®ã¡ã
æ··åç©ãã»ã©ã€ãäžã§éãã液ãç空ã§èžçº
ããæ®çç©ãé ¢é žãšãã«ïŒç³æ²¹ãšãŒãã«ããçµæ¶
åãããšããαã20 DïŒâ86°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒã®
âãããªã«ââïŒâã¢ããã€ã³ãã³âïŒâã€
ã«ã«ã«ããã«âã°ãªã·ã³ã¢ããïŒ15bïŒã2.1ïœ
ïŒ83ïŒ ïŒåŸãããã
åæ§ã«ããŠïŒ®âãã³ãžã«ãªãã·ã«ã«ããã«â
âãããã«ââïŒâã¢ããã€ã³ãã³âïŒâã€ã«
ã«ã«ããã«âã°ãªã·ã³ã¢ãã0.7ïœããããαã20 D
ïŒïŒ14°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒã®ïŒ¬âãããªã«â
âïŒâã¢ããã€ã³ãã³âïŒâã€ã«ã«ã«ããã«â
ã°ãªã·ã³ã¢ããïŒ15aïŒã0.4ïœïŒ80ïŒ ïŒåŸãã
ãã
âãããã«ââïŒâã¢ããã€ã³ãã³âïŒâã€ã«
ã«ã«ããã«âã°ãªã·ã³ã¢ãã0.7ïœããããαã20 D
ïŒïŒ14°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒã®ïŒ¬âãããªã«â
âïŒâã¢ããã€ã³ãã³âïŒâã€ã«ã«ã«ããã«â
ã°ãªã·ã³ã¢ããïŒ15aïŒã0.4ïœïŒ80ïŒ ïŒåŸãã
ãã
åæ§ã«ããŠäžèšã®ååç©ãåŸãããã
16aïŒåèäŸïŒ âãããªã«ââïŒâã¢ãã
âïŒïŒïŒïŒïŒïŒïŒâãã·ã¯ããããâïŒâã€ã«ã«
ã«ããã«âã°ãªã·ã³ã¢ããïŒ11ïŒ ïŒãèç¹233ã
238âïŒãžã¯ãã«ã¡ã¿ã³ïŒç³æ²¹ãšãŒãã«ïŒããαã
20 DïŒâ55°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 16bïŒåèäŸïŒ âãããªã«ââïŒâã¢ãã
âïŒïŒïŒïŒïŒïŒïŒâãã·ã¯ããããâïŒâã€ã«ã«
ã«ããã«âã°ãªã·ã³ã¢ããïŒ26ïŒ ïŒãèç¹153ã
160âïŒãžã¯ãã«ã¡ã¿ã³ïŒç³æ²¹ãšãŒãã«ïŒããαã
20 DïŒïŒ3°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 17a âãããªã«ââïŒâã¡ãã«ããšãã«ã¢
ã©ãã«âã°ãªã·ã³ã¢ããïŒ20ïŒ ïŒãèç¹158ã
164âïŒã¡ã¿ããŒã«ïŒãšãŒãã«ïŒãããµã³ïŒã
ãαã20 DïŒïŒ48°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 17b âãããªã«ââïŒâã¡ãã«ããšãã«ã¢
ã©ãã«âã°ãªã·ã³ã¢ããïŒ18ïŒ ïŒãèç¹184ã
186âïŒã¡ã¿ããŒã«ïŒãšãŒãã«ïŒãããµã³ïŒã
ãαã20 DïŒâ93°ïŒïœïŒ0.4ã¡ã¿ããŒã«ïŒ 18a âãããªã«ââïŒâã¢ããâïŒâããš
ãã«ããããªãã«âã°ãªã·ã³ã¢ããïŒ21ïŒ ïŒã
èç¹138ã142âïŒãžã¯ãã«ã¡ã¿ã³ïŒãšãŒãã«ïŒ
ãããµã³ïŒããαã20 DïŒâ15°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 18b âãããªã«ââïŒâã¢ããâïŒâããš
ãã«ããããªãã«âã°ãªã·ã³ã¢ããïŒ24ïŒ ïŒã
èç¹86ã92âïŒãžã¯ãã«ã¡ã¿ã³ïŒãšãŒãã«ïŒã
ããµã³ïŒããαã20 DïŒâ42°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 19a âãããªã«ââïŒâã¢ããâïŒâããš
ãã«ãããªã«âã°ãªã·ã³ã¢ããïŒ15ïŒ ïŒãèç¹
151ã158âïŒã€ãœãããããŒã«ïŒãšãŒãã«ïŒã
ãαã20 DïŒâ5°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 19b âãããªã«ââïŒâã¢ããâïŒâããš
ãã«ãããªã«âã°ãªã·ã³ã¢ããïŒ33ïŒ ïŒãèç¹
174ã175âïŒã€ãœãããããŒã«ïŒãšãŒãã«ïŒã
ãαã20 DïŒâ63°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 20a âãããªã«ââïŒâã¢ããâïŒâããš
ãã«ãã¬ãªã«âã°ãªã·ã³ã¢ããïŒ10ïŒ ïŒããαã
20 DïŒâ4°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 20b âãããªã«ââïŒâã¢ããâïŒâããš
ãã«ãã¬ãªã«âã°ãªã·ã³ã¢ããïŒ30ïŒ ïŒãèç¹
138ã141âïŒãšãŒãã«ïŒãããµã³ïŒããαã20 DïŒ
â65°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 21a âãããªã«ââïŒâã¢ããâïŒâïŒïŒ
âãããã«ïŒâããããªãã«âã°ãªã·ã³ã¢ãã
ïŒ10ïŒ ïŒãèç¹115ã120âããαã20 DïŒâ9°ïŒïœïŒ
0.5ã¡ã¿ããŒã«ïŒ 21b âãããªã«ââïŒâã¢ããâïŒâïŒïŒ
âãããã«ïŒâããããªãã«âã°ãªã·ã³ã¢ãã
ïŒ25ïŒ ïŒãèç¹113ã120âããαã20 DïŒâ34°ïŒïœïŒ
0.5ã¡ã¿ããŒã«ïŒ å®æœäŸ 22ïŒåèäŸïŒ å®æœäŸ15ãšåæ§ã«æäœãããã ããã³ãžã«ãªã
ã·ã«ã«ããã«ä¿è·åºããæ°·é ¢é žäžã§èåæ°ŽçŽ é žã
çšããŠè±é¢ãããšãäžèšã®ååç©ãåŸãããã
âïŒïŒïŒïŒïŒïŒïŒâãã·ã¯ããããâïŒâã€ã«ã«
ã«ããã«âã°ãªã·ã³ã¢ããïŒ11ïŒ ïŒãèç¹233ã
238âïŒãžã¯ãã«ã¡ã¿ã³ïŒç³æ²¹ãšãŒãã«ïŒããαã
20 DïŒâ55°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 16bïŒåèäŸïŒ âãããªã«ââïŒâã¢ãã
âïŒïŒïŒïŒïŒïŒïŒâãã·ã¯ããããâïŒâã€ã«ã«
ã«ããã«âã°ãªã·ã³ã¢ããïŒ26ïŒ ïŒãèç¹153ã
160âïŒãžã¯ãã«ã¡ã¿ã³ïŒç³æ²¹ãšãŒãã«ïŒããαã
20 DïŒïŒ3°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 17a âãããªã«ââïŒâã¡ãã«ããšãã«ã¢
ã©ãã«âã°ãªã·ã³ã¢ããïŒ20ïŒ ïŒãèç¹158ã
164âïŒã¡ã¿ããŒã«ïŒãšãŒãã«ïŒãããµã³ïŒã
ãαã20 DïŒïŒ48°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 17b âãããªã«ââïŒâã¡ãã«ããšãã«ã¢
ã©ãã«âã°ãªã·ã³ã¢ããïŒ18ïŒ ïŒãèç¹184ã
186âïŒã¡ã¿ããŒã«ïŒãšãŒãã«ïŒãããµã³ïŒã
ãαã20 DïŒâ93°ïŒïœïŒ0.4ã¡ã¿ããŒã«ïŒ 18a âãããªã«ââïŒâã¢ããâïŒâããš
ãã«ããããªãã«âã°ãªã·ã³ã¢ããïŒ21ïŒ ïŒã
èç¹138ã142âïŒãžã¯ãã«ã¡ã¿ã³ïŒãšãŒãã«ïŒ
ãããµã³ïŒããαã20 DïŒâ15°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 18b âãããªã«ââïŒâã¢ããâïŒâããš
ãã«ããããªãã«âã°ãªã·ã³ã¢ããïŒ24ïŒ ïŒã
èç¹86ã92âïŒãžã¯ãã«ã¡ã¿ã³ïŒãšãŒãã«ïŒã
ããµã³ïŒããαã20 DïŒâ42°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 19a âãããªã«ââïŒâã¢ããâïŒâããš
ãã«ãããªã«âã°ãªã·ã³ã¢ããïŒ15ïŒ ïŒãèç¹
151ã158âïŒã€ãœãããããŒã«ïŒãšãŒãã«ïŒã
ãαã20 DïŒâ5°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 19b âãããªã«ââïŒâã¢ããâïŒâããš
ãã«ãããªã«âã°ãªã·ã³ã¢ããïŒ33ïŒ ïŒãèç¹
174ã175âïŒã€ãœãããããŒã«ïŒãšãŒãã«ïŒã
ãαã20 DïŒâ63°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 20a âãããªã«ââïŒâã¢ããâïŒâããš
ãã«ãã¬ãªã«âã°ãªã·ã³ã¢ããïŒ10ïŒ ïŒããαã
20 DïŒâ4°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 20b âãããªã«ââïŒâã¢ããâïŒâããš
ãã«ãã¬ãªã«âã°ãªã·ã³ã¢ããïŒ30ïŒ ïŒãèç¹
138ã141âïŒãšãŒãã«ïŒãããµã³ïŒããαã20 DïŒ
â65°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 21a âãããªã«ââïŒâã¢ããâïŒâïŒïŒ
âãããã«ïŒâããããªãã«âã°ãªã·ã³ã¢ãã
ïŒ10ïŒ ïŒãèç¹115ã120âããαã20 DïŒâ9°ïŒïœïŒ
0.5ã¡ã¿ããŒã«ïŒ 21b âãããªã«ââïŒâã¢ããâïŒâïŒïŒ
âãããã«ïŒâããããªãã«âã°ãªã·ã³ã¢ãã
ïŒ25ïŒ ïŒãèç¹113ã120âããαã20 DïŒâ34°ïŒïœïŒ
0.5ã¡ã¿ããŒã«ïŒ å®æœäŸ 22ïŒåèäŸïŒ å®æœäŸ15ãšåæ§ã«æäœãããã ããã³ãžã«ãªã
ã·ã«ã«ããã«ä¿è·åºããæ°·é ¢é žäžã§èåæ°ŽçŽ é žã
çšããŠè±é¢ãããšãäžèšã®ååç©ãåŸãããã
22a âãããªã«ââïŒâã¢ããâïŒâïœâ
ããã ããšãã«âãããªã«âã°ãªã·ã³ã¢ããè
åæ°ŽçŽ é žå¡©ïŒ10ïŒ ïŒãèç¹196ã210âããαã20 D
ïŒ0°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 22b âãããªã«ââïŒâã¢ããâïŒâïœâ
ããã ããšãã«âãããªã«âã°ãªã·ã³ã¢ããè
åæ°ŽçŽ é žå¡©ïŒ25ïŒ ïŒãèç¹185ã202âããαã20 D
ïŒâ51°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 補å€äŸïŒ å®æœäŸ  äžèšçµæã®é å€ãé å€æ©ã«ããå§æŸè£œé ããã
ããã ããšãã«âãããªã«âã°ãªã·ã³ã¢ããè
åæ°ŽçŽ é žå¡©ïŒ10ïŒ ïŒãèç¹196ã210âããαã20 D
ïŒ0°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 22b âãããªã«ââïŒâã¢ããâïŒâïœâ
ããã ããšãã«âãããªã«âã°ãªã·ã³ã¢ããè
åæ°ŽçŽ é žå¡©ïŒ25ïŒ ïŒãèç¹185ã202âããαã20 D
ïŒâ51°ïŒïœïŒ0.5ã¡ã¿ããŒã«ïŒ 補å€äŸïŒ å®æœäŸ  äžèšçµæã®é å€ãé å€æ©ã«ããå§æŸè£œé ããã
40mg å®æœäŸ2bã®ç©è³ª
120mg ãšããããã殿ç²
13.5mg ãŒã©ãã³
45mg ä¹³ç³
2.25mg ãšãŒãã·ã«ïŒè¶
é¡åŸ®é¡çã«åŸ®ç²ç¶
ã®ååŠçã«çŽç²ãªçªé žïŒ 6.75mg ã°ãããã殿ç²ïŒïŒïŒ ã®ããšã
ãŠïŒ å®æœäŸ  åžžæ³ã«ããäžèšçµæã®ç³è¡£é ã補é ããã
ã®ååŠçã«çŽç²ãªçªé žïŒ 6.75mg ã°ãããã殿ç²ïŒïŒïŒ ã®ããšã
ãŠïŒ å®æœäŸ  åžžæ³ã«ããäžèšçµæã®ç³è¡£é ã補é ããã
20mg å®æœäŸ2bã®ç©è³ª
60mg å¿ç©è³ª
60mg ç³è¡£ææ
å¿ç©è³ªã¯ãšããããã殿ç²ïŒéšãä¹³ç³ïŒéšåã³
ã«ãã¹ã³ã«VA64ïŒããã«ãããªãã³âããã«ã¢
ã»ããŒãå ±éåç©60ïŒ40ãPharm.Ind.1962
586ïŒïŒéšããæããç³è¡£ææã¯èç³ïŒéšããšã
ãããã殿ç²ïŒéšãçé žã«ã«ã·ãŠã ïŒéšåã³ã¿ã«
ã¯ïŒéšããæããããããŠè£œé ãããç³è¡£é ãã
次ãã§èè液æ§ã®ç®èã§è¢«èŠããã
ã«ãã¹ã³ã«VA64ïŒããã«ãããªãã³âããã«ã¢
ã»ããŒãå ±éåç©60ïŒ40ãPharm.Ind.1962
586ïŒïŒéšããæããç³è¡£ææã¯èç³ïŒéšããšã
ãããã殿ç²ïŒéšãçé žã«ã«ã·ãŠã ïŒéšåã³ã¿ã«
ã¯ïŒéšããæããããããŠè£œé ãããç³è¡£é ãã
次ãã§èè液æ§ã®ç®èã§è¢«èŠããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ æ¬¡åŒ ïŒžâNHâCR2R3âC0âNHâCH2âCOâR1
 ïŒåŒäžR1ã¯NH2åºãæå³ããR2åã³R3ã¯åäž
ã§ãç°ãªã€ãŠããããC1ãC5âã¢ã«ãã«åºãã
ãšãã«åºããã³ãžã«åºåã¯ãããã«åºãæå³ãã
åã¯ãããã«å ±éã®ççŽ ååãšäžç·ã«ïŒãïŒåã®
ççŽ ååãæããèèªæã®ç°ç³»ãæå³ããŠãã
ããåã¯ïŒïŒïŒâãããã¯ïŒïŒïŒâã€ã³ãã³ãžã€
ã«åºãæå³ããã¯ãããŒã«âïŒâã€ã«ã«ã«ãã
ã«åºãã€ã³ããŒã«âïŒâã€ã«ã«ã«ããã«åºãã·ã¯
ããã³ãã«ã«ã«ããã«åºãâãããªãžã³âïŒâ
ã€ã«ã«ã«ããã«åºãâïŒïŒïŒâãããããããª
ãžã³âïŒâã€ã«ã«ã«ããã«åºãâïŒâãªããœã
ããªãžã³âïŒâã€ã«ã«ã«ããã«åºãâïŒïŒïŒâ
ãã¢ãŸãªãžã³âïŒâã€ã«ã«ã«ããã«åºåã¯ïŒ¬â
ïŒïŒïŒâãã¢ã¶ã³âïŒâã€ã«ã«ã«ããã«åºãæå³
ããïŒã§è¡šããããããããã®ïŒ®âã¢ã·ã«èªå°
äœããªãã³ã«çççã«å®¹èªãããé žã«ãããã®
å¡©ã
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19823226241 DE3226241A1 (de) | 1982-07-14 | 1982-07-14 | N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer |
DE3226241.8 | 1982-07-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5931746A JPS5931746A (ja) | 1984-02-20 |
JPH0441156B2 true JPH0441156B2 (ja) | 1992-07-07 |
Family
ID=6168357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58127033A Granted JPS5931746A (ja) | 1982-07-14 | 1983-07-14 | ããããã®ïœâã¢ã·ã«èªå°äœ |
Country Status (6)
Country | Link |
---|---|
US (1) | US4610817A (ja) |
EP (1) | EP0099057B1 (ja) |
JP (1) | JPS5931746A (ja) |
AT (1) | ATE30238T1 (ja) |
CA (1) | CA1257748A (ja) |
DE (2) | DE3226241A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9113219D0 (en) * | 1991-06-19 | 1991-08-07 | Fujisawa Pharmaceutical Co | Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same |
US6767897B2 (en) * | 1994-05-04 | 2004-07-27 | Innapharma, Inc. | Therapeutic uses of tri-, tetra-, penta-, and polypeptides |
US5767083A (en) * | 1994-05-04 | 1998-06-16 | Innapharma, Inc. | Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
US5589460A (en) * | 1994-05-04 | 1996-12-31 | Innapharma, Inc. | Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1085916A (en) * | 1964-12-01 | 1967-10-04 | Nat Res Dev | O-acyl hydroxylamines |
US4041023A (en) * | 1976-04-14 | 1977-08-09 | Hoffmann-La Roche Inc. | Labelled peptides |
JPS5632307A (en) * | 1979-08-21 | 1981-04-01 | Bergwerksverband Gmbh | Manufacture of sulfur from gas containing sulfur dioxide |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3795738A (en) * | 1972-12-26 | 1974-03-05 | Abbott Lab | Use of l-propyl l-leucyl glycine amide to treat parkinson's disease |
US4018912A (en) * | 1975-07-28 | 1977-04-19 | Ayerst Mckenna And Harrison Ltd. | Tripeptide derivatives with central nervous system activity and preparation thereof |
GB1592552A (en) * | 1976-12-10 | 1981-07-08 | Inst Nat Sante Rech Med | Pseudopeptides used as medicaments |
WO1980000216A1 (en) * | 1978-07-10 | 1980-02-21 | Univ Illinois | Inhibition by peptides of tolerance to and dependence on morphine |
US4278595A (en) * | 1979-12-10 | 1981-07-14 | Vega Laboratories, Inc. | Orally active MIF analogs with an effect on the central nervous system |
US4395401A (en) * | 1981-09-09 | 1983-07-26 | Smithkline Beckman Corporation | Renally active dipeptides |
-
1982
- 1982-07-14 DE DE19823226241 patent/DE3226241A1/de not_active Withdrawn
-
1983
- 1983-07-06 EP EP83106587A patent/EP0099057B1/de not_active Expired
- 1983-07-06 AT AT83106587T patent/ATE30238T1/de not_active IP Right Cessation
- 1983-07-06 DE DE8383106587T patent/DE3374066D1/de not_active Expired
- 1983-07-12 US US06/513,023 patent/US4610817A/en not_active Expired - Fee Related
- 1983-07-13 CA CA000432342A patent/CA1257748A/en not_active Expired
- 1983-07-14 JP JP58127033A patent/JPS5931746A/ja active Granted
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1085916A (en) * | 1964-12-01 | 1967-10-04 | Nat Res Dev | O-acyl hydroxylamines |
US4041023A (en) * | 1976-04-14 | 1977-08-09 | Hoffmann-La Roche Inc. | Labelled peptides |
JPS5632307A (en) * | 1979-08-21 | 1981-04-01 | Bergwerksverband Gmbh | Manufacture of sulfur from gas containing sulfur dioxide |
Also Published As
Publication number | Publication date |
---|---|
EP0099057A2 (de) | 1984-01-25 |
EP0099057A3 (en) | 1984-09-12 |
DE3374066D1 (en) | 1987-11-19 |
DE3226241A1 (de) | 1984-01-26 |
ATE30238T1 (de) | 1987-10-15 |
EP0099057B1 (de) | 1987-10-14 |
US4610817A (en) | 1986-09-09 |
JPS5931746A (ja) | 1984-02-20 |
CA1257748A (en) | 1989-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6410548B2 (en) | Spiropiperidine derivatives as melanocortin receptor agonists | |
KR880000890B1 (ko) | ëê³ ëŠ¬ íí©ë¬Œì ì ì¡°ë°©ë² | |
JPH06340691A (ja) | ããããé¡ | |
WO1999064002A1 (en) | Spiropiperidine derivatives as melanocortin receptor agonists | |
EP0198898A1 (en) | DIPEPTIDE COMPOUNDS WITH PHARMACEUTICAL EFFECTIVENESS AND THEIR COMPOSITIONS. | |
NO159017B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,2,3,4-tetrahydroisokinolin-3-karboksylsyre-derivater. | |
US4218474A (en) | Derivatives of L- and DL-4-hydroxyphenylglycine | |
JPH0132239B2 (ja) | ||
JPS6120544B2 (ja) | ||
JPH04253995A (ja) | æ°èŠããããååç© | |
NO861141L (no) | Fremgangsmaate ved fremstilling av therapeutisk virksomme n,n[-dialkylguanidino-dipeptider. | |
JPH0811746B2 (ja) | æ°èŠããããååç© | |
US4906615A (en) | Substituted dipeptides as inhibitors of enkephalinases | |
US5098888A (en) | New heterocyclic tripeptide compounds | |
JP2000327575A (ja) | ãžã±ãããã©ãžã³èªå°äœå«æçççŸæ£æ²»çå€ããã³æ°èŠãªãžã±ãããã©ãžã³èªå°äœ | |
NO832648L (no) | Nye derivater av 2-aza-bicyclo(2.2.2)oktan-3-karbonsyre, fremgangsmaate til deres fremstilling, middel inneholdende dette og deres anvendelse samt 2-aza-bicyclo(2.2.2)oktan-3-karbonsyre som mellomstoff og fremg. til deres fremst | |
EP0077274B1 (en) | 3-amino-2-hydroxy-4-phenylbutanoic acid derivatives and pharmaceutical composition containing the same | |
JPH0441156B2 (ja) | ||
AU617224B2 (en) | Pyrrolidone-2-carboxylic acid derivatives having a psychotropic action | |
DE60010711T2 (de) | Amido-spiropiperidine promovieren die freisetzung von wachstumshormonen | |
US5359087A (en) | Bioactive quisqualic acid analogs | |
US4278595A (en) | Orally active MIF analogs with an effect on the central nervous system | |
US5286715A (en) | New adamantyl comprising tripeptides, derivatives and hydrochlorides thereof, their preparation and use | |
US4610818A (en) | N-acyl derivatives of dipeptides, their preparation and their use in the therapy of disorders, and agents for this purpose | |
KR880001007B1 (ko) | ë¹ì¬ìŽíŽëŠ íí©ë¬Œì ì ì¡° ë°©ë² |